STOCK TITAN

Worksport flags going-concern doubt in Q3 2026

Worksport has until February 9, 2027, to meet Nasdaq's bid-price test, while management reports substantial doubt about continued operations.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Worksport Ltd. reported third-quarter 2026 net sales of $7,228,298, up 44.2% from $5,013,872 a year earlier. Gross profit rose 39.5% to $2,188,707, while net loss narrowed 27.0% to $3,599,392 from $4,928,679. Cost of sales increased 46.3% to $5,039,591.

For the first nine months, operating cash used was $12,043,036, versus $11,190,182. Cash and equivalents were $2,528,222 at September 30, with $1,818,887 available on its revolving credit line. Management said conditions cast substantial doubt on the company’s ability to continue as a going concern within one year after the financial statements are issued, and that additional financing may be needed.

During the nine months, Worksport sold 4,006,728 shares under its at-the-market agreement for $4,496,875 gross and $4,357,740 net proceeds. A warrant inducement generated $2,304,253 from exercise of 3,840,421 existing warrants at $0.60 per share and issued 4,800,526 new warrants with a $0.60 exercise price. Nasdaq notified the company it no longer met the $1.00 minimum bid-price requirement; it has until February 9, 2027, to regain compliance.

2 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 3 points

How the balance works

Positive

  • Moderate pointThird-quarter net sales reached $7,228,298, up 44.2% year over year.
  • Moderate pointThird-quarter net loss narrowed to $3,599,392 from $4,928,679.

Negative

  • Major pointGoing-concern disclosure identifies substantial doubt about continued operations.
  • Moderate pointNine-month operating cash use was $12,043,036, versus $11,190,182.
  • Moderate pointNasdaq notice sets a February 9, 2027 deadline to regain $1.00 minimum bid-price compliance.

Filing Explained

The approved options create potential dilution only upon exercise, while transaction bonuses transfer a stated share of consideration only if specified deals occur.

Worksport’s Form 10-Q reports that on November 9, 2026, its board approved options to purchase 2,200,000 shares for CEO Steven Rossi and 50,000 shares for each of four directors; any portion exceeding available 2022 Plan shares cannot be exercised unless shares later become available or shareholders approve a reserve increase. If exercised, the options would add common shares and reduce existing holders’ percentage ownership.

The board also approved an option exchange program, and Worksport says it is evaluating the modification’s incremental compensation cost. Separately, the approved arrangements provide a cash-or-in-kind bonus equal to 10% of consideration received on a subsidiary sale and a 4% pool for a qualified strategic transaction involving Worksport or Terravis Energy; the CFO’s award under that pool is 1.00% of transaction consideration. Both arrangements have stated Section 280G cutback and change-in-control noncompetition-agreement conditions.

If sufficient plan shares have not become available by the 2027 annual meeting, Worksport says it will ask shareholders to increase the reserve, and any excess portion of the grant will be forfeited if approval is not obtained.

Third-quarter net sales $7,228,298 Three months ended September 30, 2026; $5,013,872 in 2025
Third-quarter net loss $3,599,392 Three months ended September 30, 2026; $4,928,679 in 2025
Cash and cash equivalents $2,528,222 As of September 30, 2026
Net cash used in operating activities $12,043,036 used Nine months ended September 30, 2026; $11,190,182 used in 2025
ATM shares sold 4,006,728 shares Nine months ended September 30, 2026
ATM net proceeds $4,357,740 Nine months ended September 30, 2026
Warrant exercise proceeds $2,304,253 August 2026 warrant inducement
Nasdaq bid-price compliance deadline February 9, 2027 Deadline to regain the $1.00 minimum bid-price requirement
going concern financial
"continue as a going concern"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
At The Market Offering Agreement financial
"entered into an At The Market Offering Agreement"
An at-the-market offering agreement is a contract that lets a company sell newly issued shares directly into the open market through a broker, at whatever price the stock is trading at that moment. For investors this matters because it can increase the number of shares available (which may dilute existing ownership) while providing a flexible, often faster way for the company to raise cash without fixing a price, similar to a vendor selling small batches at current market stalls rather than setting a single fixed price.
non-cash deemed dividend financial
"recorded as a non-cash deemed dividend"
A non-cash deemed dividend is a distribution treated like dividend income by tax or accounting rules even though shareholders receive no cash — for example when a company transfers assets, cancels debt, or issues shares in a way that is treated as a payout. It matters to investors because it can create taxable income, change a company’s balance sheet or share count, and affect future cash available for ordinary dividends; think of getting a gift card instead of cash but still owing tax on its value.
cashless feature financial
"warrants contained a cashless feature"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were Worksport (WKSP) sales and losses in Q3 2026?

For the three months ended September 30, 2026, Worksport reported net sales of $7,228,298 and net loss of $3,599,392; the comparable 2025 figures were $5,013,872 and $4,928,679.

How much cash and credit availability did Worksport (WKSP) report?

As of September 30, 2026, Worksport had $2,528,222 in cash and cash equivalents and $1,818,887 available under its revolving credit line. Management said conditions cast substantial doubt on the company’s ability to continue as a going concern within one year after the financial statements are issued.

When must Worksport (WKSP) regain Nasdaq's minimum bid-price compliance?

Worksport has until February 9, 2027, to regain compliance by maintaining a closing bid price of at least $1.00 per share for at least 10 consecutive business days. If it does not meet the deadline, it may be eligible for an additional 180-calendar-day compliance period if it meets applicable conditions.

What commission does Worksport (WKSP) pay under its ATM agreement?

H.C. Wainwright & Co., LLC is entitled to a commission of 3.0% of gross proceeds from shares sold under the agreement, and Worksport agreed to reimburse certain specified expenses. Sales are subject to Form S-3 limits on primary offerings during any rolling 12-month period because the company’s public float is below $75.0 million.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
0001096275 Worksport Ltd false --12-31 Q3 2026 0.001 0.001 0.001 0.001 0.001 0.001 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 10,000,000 100 100 100 100 0 0 0 0 427,612 427,612 427,812 427,812 0.001 0.001 45,000,000 45,000,000 19,993,672 19,993,672 9,814,665 9,814,665 5.5 1 1 1 1 0 100 22.9 22.9 22.9 100 100 100 21 21 21 3 2 2 July 18, 2028 September 1, 2027 http://fasb.org/us-gaap/2026#PrimeRateMember 0.26 1.12 13,605,813 11,902,961 0.75 2.44 6,563,228 5,377,750 45,000,000 19,993,672 7,589,036 1 1 1 1 1 3 10 10 30.00 3 February 9, 2036 1 January 5, 2036 3 January 5, 2036 January 5, 2036 2 February 9, 2036 0.25 12 0.75 July 31, 2036 0.5 2 July 31, 2036 3 February 9, 2036 6 July 27, 2036 6 July 27, 2036 July 27, 2036 2 2 50,000 50,000 50,000 false false false false On September 4, 2024, the Company, through its wholly owned subsidiary, Worksport USA Operations Corporation, entered into a $1,487,200 credit and security agreement with an external lending entity with a final maturity date of September 1, 2027, which is 36 months from initial funding. Upon transaction close, the Company received net proceeds of $1,412,750 (net of issuance costs of $43,735). The Company and its wholly owned subsidiary, Worksport New York Operations Corporation, serve as guarantors on the loan. For collateral, the lender holds a first position on the Company’s equipment, which is primarily manufacturing and warehousing equipment. Interest on the loan is based on the prime rate plus 700 basis points per annum. At September 30, 2026, the outstanding balance of this loan was $1,045,488 (net of issuance costs of $15,034). On July 19, 2024, the Company, as the guarantor, and Worksport New York Operations Corporation as well as Worksport USA Operations Corporation, entered into a $6,000,000 Revolving Financing and Assignment Agreement (the “Agreement”) with an external lending entity with a maturity date of July 18, 2026, or 24 months. The Agreement includes an autorenewal provision whereby the Agreement renews and extends for an additional 24 months at the time of original maturity, or until July 18, 2028. On July 18, 2026, the Agreement was renewed. Upon original transaction close, the Company drew down approximately $5.06 million of the Agreement, net of $790,000 of interest reserve required to be withheld to ensure interest payments by the Company. The Company used $4.73 million of the drawn down amount to refinance the Company’s mortgage on the Company’s real property located at 2500 North America Dr. in West Seneca, New York, and additionally drew approximately $330,000 to fund operations. At September 30, 2026, the outstanding balance of this loan was $3,283,500. For collateral, the lender holds a first position on the Company’s major asset classes (accounts receivable, the factory in New York, and inventory) other than the Company’s equipment. A non-usage fee of 0.25% is assessed quarterly and applied to the difference between the quarter’s average daily outstanding loan balance and the total credit facility amount. As of September 30, 2026, the Company had an available balance of $1,818,887 to borrow under the Agreement. 00010962752026-01-012026-09-30 xbrli:shares 00010962752026-11-10 thunderdome:item iso4217:USD 00010962752026-09-30 00010962752025-12-31 iso4217:USDxbrli:shares 0001096275us-gaap:SeriesAPreferredStockMember2026-09-30 0001096275us-gaap:SeriesAPreferredStockMember2025-12-31 0001096275us-gaap:SeriesBPreferredStockMember2026-09-30 0001096275us-gaap:SeriesBPreferredStockMember2025-12-31 0001096275us-gaap:SeriesCPreferredStockMember2026-09-30 0001096275us-gaap:SeriesCPreferredStockMember2025-12-31 00010962752026-07-012026-09-30 00010962752025-07-012025-09-30 00010962752025-01-012025-09-30 0001096275us-gaap:PreferredStockMember2025-06-30 0001096275us-gaap:CommonStockMember2025-06-30 0001096275us-gaap:AdditionalPaidInCapitalMember2025-06-30 0001096275wksp:ShareSubscriptionsReceivableMember2025-06-30 0001096275wksp:ShareSubscriptionPayableMember2025-06-30 0001096275us-gaap:RetainedEarningsMember2025-06-30 0001096275us-gaap:AccumulatedTranslationAdjustmentMember2025-06-30 00010962752025-06-30 0001096275us-gaap:PreferredStockMember2025-07-012025-09-30 0001096275us-gaap:CommonStockMember2025-07-012025-09-30 0001096275us-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-30 0001096275wksp:ShareSubscriptionsReceivableMember2025-07-012025-09-30 0001096275wksp:ShareSubscriptionPayableMember2025-07-012025-09-30 0001096275us-gaap:RetainedEarningsMember2025-07-012025-09-30 0001096275us-gaap:AccumulatedTranslationAdjustmentMember2025-07-012025-09-30 0001096275us-gaap:PreferredStockMemberwksp:RegulationAOfferingMember2025-07-012025-09-30 0001096275us-gaap:CommonStockMemberwksp:RegulationAOfferingMember2025-07-012025-09-30 0001096275us-gaap:AdditionalPaidInCapitalMemberwksp:RegulationAOfferingMember2025-07-012025-09-30 0001096275wksp:ShareSubscriptionsReceivableMemberwksp:RegulationAOfferingMember2025-07-012025-09-30 0001096275wksp:ShareSubscriptionPayableMemberwksp:RegulationAOfferingMember2025-07-012025-09-30 0001096275us-gaap:RetainedEarningsMemberwksp:RegulationAOfferingMember2025-07-012025-09-30 0001096275us-gaap:AccumulatedTranslationAdjustmentMemberwksp:RegulationAOfferingMember2025-07-012025-09-30 0001096275wksp:RegulationAOfferingMember2025-07-012025-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberus-gaap:PreferredStockMember2025-07-012025-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberus-gaap:CommonStockMember2025-07-012025-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberus-gaap:AdditionalPaidInCapitalMember2025-07-012025-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberwksp:ShareSubscriptionsReceivableMember2025-07-012025-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberwksp:ShareSubscriptionPayableMember2025-07-012025-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberus-gaap:RetainedEarningsMember2025-07-012025-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberus-gaap:AccumulatedTranslationAdjustmentMember2025-07-012025-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMember2025-07-012025-09-30 0001096275wksp:WarrantsMemberus-gaap:PreferredStockMemberwksp:RegulationAOfferingMember2025-07-012025-09-30 0001096275wksp:WarrantsMemberus-gaap:CommonStockMemberwksp:RegulationAOfferingMember2025-07-012025-09-30 0001096275wksp:WarrantsMemberus-gaap:AdditionalPaidInCapitalMemberwksp:RegulationAOfferingMember2025-07-012025-09-30 0001096275wksp:WarrantsMemberwksp:ShareSubscriptionsReceivableMemberwksp:RegulationAOfferingMember2025-07-012025-09-30 0001096275wksp:WarrantsMemberwksp:ShareSubscriptionPayableMemberwksp:RegulationAOfferingMember2025-07-012025-09-30 0001096275wksp:WarrantsMemberus-gaap:RetainedEarningsMemberwksp:RegulationAOfferingMember2025-07-012025-09-30 0001096275wksp:WarrantsMemberus-gaap:AccumulatedTranslationAdjustmentMemberwksp:RegulationAOfferingMember2025-07-012025-09-30 0001096275wksp:WarrantsMemberwksp:RegulationAOfferingMember2025-07-012025-09-30 0001096275us-gaap:PreferredStockMember2025-09-30 0001096275us-gaap:CommonStockMember2025-09-30 0001096275us-gaap:AdditionalPaidInCapitalMember2025-09-30 0001096275wksp:ShareSubscriptionsReceivableMember2025-09-30 0001096275wksp:ShareSubscriptionPayableMember2025-09-30 0001096275us-gaap:RetainedEarningsMember2025-09-30 0001096275us-gaap:AccumulatedTranslationAdjustmentMember2025-09-30 00010962752025-09-30 0001096275us-gaap:PreferredStockMember2026-06-30 0001096275us-gaap:CommonStockMember2026-06-30 0001096275us-gaap:AdditionalPaidInCapitalMember2026-06-30 0001096275wksp:ShareSubscriptionsReceivableMember2026-06-30 0001096275wksp:ShareSubscriptionPayableMember2026-06-30 0001096275us-gaap:RetainedEarningsMember2026-06-30 0001096275us-gaap:AccumulatedTranslationAdjustmentMember2026-06-30 00010962752026-06-30 0001096275us-gaap:PreferredStockMember2026-07-012026-09-30 0001096275us-gaap:CommonStockMember2026-07-012026-09-30 0001096275us-gaap:AdditionalPaidInCapitalMember2026-07-012026-09-30 0001096275wksp:ShareSubscriptionsReceivableMember2026-07-012026-09-30 0001096275wksp:ShareSubscriptionPayableMember2026-07-012026-09-30 0001096275us-gaap:RetainedEarningsMember2026-07-012026-09-30 0001096275us-gaap:AccumulatedTranslationAdjustmentMember2026-07-012026-09-30 0001096275us-gaap:PreferredStockMember2026-09-30 0001096275us-gaap:CommonStockMember2026-09-30 0001096275us-gaap:AdditionalPaidInCapitalMember2026-09-30 0001096275wksp:ShareSubscriptionsReceivableMember2026-09-30 0001096275wksp:ShareSubscriptionPayableMember2026-09-30 0001096275us-gaap:RetainedEarningsMember2026-09-30 0001096275us-gaap:AccumulatedTranslationAdjustmentMember2026-09-30 0001096275us-gaap:PreferredStockMember2024-12-31 0001096275us-gaap:CommonStockMember2024-12-31 0001096275us-gaap:AdditionalPaidInCapitalMember2024-12-31 0001096275wksp:ShareSubscriptionsReceivableMember2024-12-31 0001096275wksp:ShareSubscriptionPayableMember2024-12-31 0001096275us-gaap:RetainedEarningsMember2024-12-31 0001096275us-gaap:AccumulatedTranslationAdjustmentMember2024-12-31 00010962752024-12-31 0001096275us-gaap:PreferredStockMember2025-01-012025-09-30 0001096275us-gaap:CommonStockMember2025-01-012025-09-30 0001096275us-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-30 0001096275wksp:ShareSubscriptionsReceivableMember2025-01-012025-09-30 0001096275wksp:ShareSubscriptionPayableMember2025-01-012025-09-30 0001096275us-gaap:RetainedEarningsMember2025-01-012025-09-30 0001096275us-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-09-30 0001096275us-gaap:PreferredStockMemberwksp:RegulationAOfferingMember2025-01-012025-09-30 0001096275us-gaap:CommonStockMemberwksp:RegulationAOfferingMember2025-01-012025-09-30 0001096275us-gaap:AdditionalPaidInCapitalMemberwksp:RegulationAOfferingMember2025-01-012025-09-30 0001096275wksp:ShareSubscriptionsReceivableMemberwksp:RegulationAOfferingMember2025-01-012025-09-30 0001096275wksp:ShareSubscriptionPayableMemberwksp:RegulationAOfferingMember2025-01-012025-09-30 0001096275us-gaap:RetainedEarningsMemberwksp:RegulationAOfferingMember2025-01-012025-09-30 0001096275us-gaap:AccumulatedTranslationAdjustmentMemberwksp:RegulationAOfferingMember2025-01-012025-09-30 0001096275wksp:RegulationAOfferingMember2025-01-012025-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberus-gaap:PreferredStockMember2025-01-012025-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberus-gaap:CommonStockMember2025-01-012025-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberus-gaap:AdditionalPaidInCapitalMember2025-01-012025-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberwksp:ShareSubscriptionsReceivableMember2025-01-012025-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberwksp:ShareSubscriptionPayableMember2025-01-012025-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberus-gaap:RetainedEarningsMember2025-01-012025-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberus-gaap:AccumulatedTranslationAdjustmentMember2025-01-012025-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMember2025-01-012025-09-30 0001096275wksp:WarrantsMemberus-gaap:PreferredStockMemberwksp:RegulationAOfferingMember2025-01-012025-09-30 0001096275wksp:WarrantsMemberus-gaap:CommonStockMemberwksp:RegulationAOfferingMember2025-01-012025-09-30 0001096275wksp:WarrantsMemberus-gaap:AdditionalPaidInCapitalMemberwksp:RegulationAOfferingMember2025-01-012025-09-30 0001096275wksp:WarrantsMemberwksp:ShareSubscriptionsReceivableMemberwksp:RegulationAOfferingMember2025-01-012025-09-30 0001096275wksp:WarrantsMemberwksp:ShareSubscriptionPayableMemberwksp:RegulationAOfferingMember2025-01-012025-09-30 0001096275wksp:WarrantsMemberus-gaap:RetainedEarningsMemberwksp:RegulationAOfferingMember2025-01-012025-09-30 0001096275wksp:WarrantsMemberus-gaap:AccumulatedTranslationAdjustmentMemberwksp:RegulationAOfferingMember2025-01-012025-09-30 0001096275wksp:WarrantsMemberwksp:RegulationAOfferingMember2025-01-012025-09-30 0001096275us-gaap:PreferredStockMember2025-12-31 0001096275us-gaap:CommonStockMember2025-12-31 0001096275us-gaap:AdditionalPaidInCapitalMember2025-12-31 0001096275wksp:ShareSubscriptionsReceivableMember2025-12-31 0001096275wksp:ShareSubscriptionPayableMember2025-12-31 0001096275us-gaap:RetainedEarningsMember2025-12-31 0001096275us-gaap:AccumulatedTranslationAdjustmentMember2025-12-31 0001096275us-gaap:PreferredStockMember2026-01-012026-09-30 0001096275us-gaap:CommonStockMember2026-01-012026-09-30 0001096275us-gaap:AdditionalPaidInCapitalMember2026-01-012026-09-30 0001096275wksp:ShareSubscriptionsReceivableMember2026-01-012026-09-30 0001096275wksp:ShareSubscriptionPayableMember2026-01-012026-09-30 0001096275us-gaap:RetainedEarningsMember2026-01-012026-09-30 0001096275us-gaap:AccumulatedTranslationAdjustmentMember2026-01-012026-09-30 0001096275wksp:InducementWarrantsMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001096275wksp:InducementWarrantsMemberus-gaap:CommonStockMember2026-01-012026-09-30 0001096275wksp:InducementWarrantsMemberus-gaap:AdditionalPaidInCapitalMember2026-01-012026-09-30 0001096275wksp:InducementWarrantsMemberwksp:ShareSubscriptionsReceivableMember2026-01-012026-09-30 0001096275wksp:InducementWarrantsMemberwksp:ShareSubscriptionPayableMember2026-01-012026-09-30 0001096275wksp:InducementWarrantsMemberus-gaap:RetainedEarningsMember2026-01-012026-09-30 0001096275wksp:InducementWarrantsMemberus-gaap:AccumulatedTranslationAdjustmentMember2026-01-012026-09-30 0001096275wksp:InducementWarrantsMember2026-01-012026-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberus-gaap:PreferredStockMember2026-01-012026-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberus-gaap:CommonStockMember2026-01-012026-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberus-gaap:AdditionalPaidInCapitalMember2026-01-012026-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberwksp:ShareSubscriptionsReceivableMember2026-01-012026-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberwksp:ShareSubscriptionPayableMember2026-01-012026-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberus-gaap:RetainedEarningsMember2026-01-012026-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMemberus-gaap:AccumulatedTranslationAdjustmentMember2026-01-012026-09-30 0001096275wksp:ConversionOfSeriesCPreferredStockIntoCommonStockMember2026-01-012026-09-30 0001096275wksp:ReclassificationFromProfessionalFeesMember2025-07-012025-09-30 0001096275wksp:ReclassificationFromProfessionalFeesMember2025-01-012025-09-30 0001096275wksp:ReclassificationFromInterestIncomeMember2025-07-012025-09-30 0001096275wksp:ReclassificationFromInterestIncomeMember2025-01-012025-09-30 0001096275wksp:ReclassificationsFromInvestmentsMember2025-12-31 00010962752026-01-122026-09-30 0001096275wksp:AtTheMarketOfferingAgreementMember2022-09-30 xbrli:pure 0001096275wksp:AtTheMarketOfferingAgreementMember2022-09-302022-09-30 0001096275wksp:AtTheMarketOfferingAgreementMember2025-11-14 0001096275wksp:AtTheMarketOfferingAgreementMember2026-01-012026-09-30 0001096275wksp:RegisteredDirectOffering192500SharesOfCommonStockMember2023-11-022023-11-02 0001096275wksp:PrefundedWarrantSharesMemberwksp:RegisteredDirectOffering192500SharesOfCommonStockMember2023-11-022023-11-02 0001096275wksp:PrivateSaleWarrantsShareMemberwksp:RegisteredDirectOffering192500SharesOfCommonStockMember2023-11-022023-11-02 0001096275wksp:PrivateSaleWarrantsShareMemberwksp:RegisteredDirectOffering192500SharesOfCommonStockMember2023-11-02 utr:Y 0001096275wksp:RegisteredDirectOffering237224SharesOfCommonStockMember2024-03-202024-03-20 0001096275wksp:PrefundedWarrantSharesMemberwksp:RegisteredDirectOffering237224SharesOfCommonStockMember2024-03-202024-03-20 0001096275wksp:PrivateSaleWarrantsShareMemberwksp:RegisteredDirectOffering237224SharesOfCommonStockMember2024-03-202024-03-20 0001096275wksp:PrivateSaleWarrantsShareMemberwksp:RegisteredDirectOffering237224SharesOfCommonStockMember2024-03-20 0001096275wksp:PrivateSaleWarrantsShareMemberwksp:RegisteredDirectOfferingMember2024-03-20 0001096275wksp:May2024ShareholderWarrantSharesMember2024-05-29 0001096275wksp:May2024ShareholderWarrantSharesMember2025-02-272025-02-27 0001096275wksp:May2024ShareholderWarrantSharesMember2025-02-26 0001096275wksp:May2024ShareholderWarrantSharesMember2025-02-27 0001096275wksp:February2025InducementWarrantMember2025-02-272025-02-27 0001096275wksp:February2025InducementWarrantMember2025-02-27 0001096275wksp:RegulationAOfferingMember2025-06-132025-06-13 0001096275wksp:RegulationAOfferingMember2025-06-13 0001096275us-gaap:SeriesCPreferredStockMemberwksp:RegulationAOfferingMember2025-06-132025-06-13 0001096275wksp:SeriesCPreferredStockSharesMemberwksp:RegulationAOfferingMember2025-06-13 0001096275wksp:RegulationAOfferingMember2025-10-012025-10-31 0001096275wksp:RegulationAOfferingMember2025-10-31 0001096275wksp:December2025InducementWarrantSharesMember2025-12-11 0001096275wksp:December2025InducementWarrantSharesMember2025-12-112025-12-11 0001096275wksp:December2025InducementWarrantSharesMember2026-01-012026-03-31 0001096275wksp:FirstSecuritiesPurchaseAgreementMember2026-06-172026-06-17 0001096275wksp:FirstAgreementWarrantsMemberwksp:FirstSecuritiesPurchaseAgreementMember2026-06-17 0001096275wksp:FirstSecuritiesPurchaseAgreementMember2026-06-17 0001096275wksp:FirstAgreementWarrantsCashlessMemberwksp:FirstSecuritiesPurchaseAgreementMember2026-06-17 0001096275wksp:FirstAgreementWarrantsCashlessMemberwksp:FirstSecuritiesPurchaseAgreementMember2026-06-172026-06-17 0001096275wksp:SecondSecuritiesPurchaseAgreementMember2026-06-182026-06-18 0001096275wksp:SecondSecuritiesPurchaseAgreementMember2026-06-18 0001096275wksp:August2026InducementWarrantsMember2026-08-27 0001096275wksp:August2026InducementWarrantsMember2026-08-272026-08-27 0001096275wksp:ExistingWarrantsMember2026-08-272026-08-27 0001096275us-gaap:BuildingMember2026-09-30 0001096275us-gaap:BuildingMember2025-12-31 0001096275wksp:ManufacturingEquipmentMember2026-09-30 0001096275wksp:ManufacturingEquipmentMember2025-12-31 0001096275us-gaap:LandMember2026-09-30 0001096275us-gaap:LandMember2025-12-31 0001096275us-gaap:LeaseholdImprovementsMember2026-09-30 0001096275us-gaap:LeaseholdImprovementsMember2025-12-31 0001096275wksp:ProductMoldsMember2026-09-30 0001096275wksp:ProductMoldsMember2025-12-31 0001096275wksp:WarehouseEquipmentMember2026-09-30 0001096275wksp:WarehouseEquipmentMember2025-12-31 0001096275wksp:ElectricalEquipmentMember2026-09-30 0001096275wksp:ElectricalEquipmentMember2025-12-31 0001096275us-gaap:AutomobilesMember2026-09-30 0001096275us-gaap:AutomobilesMember2025-12-31 0001096275us-gaap:FurnitureAndFixturesMember2026-09-30 0001096275us-gaap:FurnitureAndFixturesMember2025-12-31 0001096275us-gaap:ComputerEquipmentMember2026-09-30 0001096275us-gaap:ComputerEquipmentMember2025-12-31 0001096275wksp:ManufacturingEquipmentMemberwksp:ReleaseFromAgreementMember2026-09-30 0001096275us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2026-09-30 0001096275us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2025-12-31 0001096275us-gaap:LicensingAgreementsMember2026-09-30 0001096275us-gaap:LicensingAgreementsMember2025-12-31 0001096275us-gaap:PatentsMember2026-09-30 0001096275us-gaap:PatentsMember2025-12-31 0001096275us-gaap:TrademarksMember2026-09-30 0001096275us-gaap:TrademarksMember2025-12-31 0001096275us-gaap:OtherIntangibleAssetsMember2026-09-30 0001096275us-gaap:OtherIntangibleAssetsMember2025-12-31 0001096275us-gaap:SeriesAPreferredStockMember2019-12-31 0001096275us-gaap:SeriesBPreferredStockMember2020-12-31 0001096275us-gaap:SeriesCPreferredStockMember2025-01-012025-12-31 0001096275us-gaap:SeriesCPreferredStockMember2026-01-012026-09-30 0001096275us-gaap:RestrictedStockMemberwksp:ConsultingExpenseMember2026-01-012026-09-30 0001096275us-gaap:RestrictedStockMemberwksp:ConsultingExpenseMember2026-09-30 0001096275us-gaap:RestrictedStockMember2026-01-012026-09-30 0001096275us-gaap:RestrictedStockMemberwksp:SalaryExpenseMember2026-09-30 0001096275wksp:WarrantsMemberwksp:AtTheMarketOfferingAgreementMember2026-01-012026-09-30 0001096275wksp:AtTheMarketOfferingAgreementMember2025-01-012025-09-30 0001096275wksp:RestrictedStockAndOptionsMember2025-01-012025-09-30 0001096275us-gaap:RestrictedStockMemberwksp:ConsultingExpenseAndMarketingExpenseMember2025-09-30 0001096275wksp:May2024ShareholderWarrantSharesMember2025-09-30 0001096275wksp:ExercisableWarrantSharesMember2025-01-012025-09-30 0001096275wksp:ExercisableWarrantSharesMember2025-09-30 0001096275wksp:May2024ShareholderWarrantSharesMember2025-01-012025-09-30 0001096275wksp:RegulationAOfferingMember2025-09-30 utr:sqft 0001096275wksp:OfficeSpaceRdFacilityMember2025-04-01 0001096275wksp:OfficeSpaceRdFacilityMember2025-05-012025-05-01 0001096275wksp:OfficeSpaceRdFacilityMember2025-05-01 0001096275wksp:OfficeSpaceRdFacilityTerravisEnergySubsidiaryMember2025-07-14 0001096275wksp:OfficeSpaceRdFacilityTerravisEnergySubsidiaryMember2025-07-182025-07-18 0001096275wksp:OfficeSpaceRdFacilityTerravisEnergySubsidiaryMember2025-07-18 0001096275us-gaap:RevolvingCreditFacilityMemberwksp:RevolvingFinancingAndAssignmentAgreementMember2026-09-30 0001096275us-gaap:RevolvingCreditFacilityMemberwksp:RevolvingFinancingAndAssignmentAgreementMember2025-12-31 0001096275wksp:CreditAndSecurityAgreementMember2026-09-30 0001096275wksp:CreditAndSecurityAgreementMember2025-12-31 0001096275us-gaap:RevolvingCreditFacilityMemberwksp:RevolvingFinancingAndAssignmentAgreementMemberwksp:ExternalLendingEntityMember2024-07-19 utr:M 0001096275us-gaap:RevolvingCreditFacilityMemberwksp:RevolvingFinancingAndAssignmentAgreementMemberwksp:ExternalLendingEntityMember2024-07-192024-07-19 0001096275us-gaap:RevolvingCreditFacilityMemberwksp:RevolvingFinancingAndAssignmentAgreementMemberwksp:ExternalLendingEntityMember2026-09-30 0001096275us-gaap:RevolvingCreditFacilityMemberwksp:CreditAndSecurityAgreementMemberwksp:ExternalLendingEntityMember2024-09-04 0001096275us-gaap:RevolvingCreditFacilityMemberwksp:CreditAndSecurityAgreementMemberwksp:ExternalLendingEntityMember2024-09-042024-09-04 00010962752024-09-042024-09-04 0001096275us-gaap:RevolvingCreditFacilityMemberwksp:CreditAndSecurityAgreementMemberwksp:ExternalLendingEntityMember2026-09-30 0001096275wksp:August2026InducementWarrantsMember2026-08-012026-08-31 0001096275wksp:August2026InducementWarrantsMember2026-09-012026-09-30 0001096275wksp:December2025InducementWarrantSharesMember2025-12-012025-12-31 0001096275wksp:December2025InducementWarrantSharesMember2026-01-012026-01-31 0001096275wksp:September2025InducementWarrantSharesMember2025-09-02 0001096275wksp:CommonStockWarrantSharesMember2025-09-02 0001096275wksp:CommonStockWarrantSharesMember2025-01-012025-12-31 0001096275wksp:CommonStockWarrantSharesMember2026-01-012026-09-30 0001096275wksp:RegulationAOfferingMember2025-09-022025-09-02 0001096275wksp:RegulationAOfferingMember2025-09-02 0001096275us-gaap:SeriesCPreferredStockMemberwksp:RegulationAOfferingMember2025-09-022025-09-02 0001096275wksp:RegulationAOfferingMember2025-10-152025-10-15 0001096275wksp:InvestorsWarrantSharesMemberwksp:RegulationAOfferingMember2026-01-012026-09-30 0001096275wksp:RegulationAOfferingMember2026-01-012026-09-30 0001096275wksp:February2025InducementWarrantSharesMember2025-02-27 0001096275wksp:February2025InducementWarrantSharesMember2025-02-272025-02-27 0001096275wksp:RegisteredDirectOffering237224SharesOfCommonStockMember2024-01-012024-12-31 0001096275wksp:PrefundedWarrantSharesMemberwksp:RegisteredDirectOffering237224SharesOfCommonStockMember2024-01-012024-12-31 0001096275wksp:ExercisableWarrantSharesMemberwksp:RegisteredDirectOffering237224SharesOfCommonStockMember2024-01-012024-12-31 0001096275wksp:ExercisableWarrantAndPrefundedWarrantsMemberwksp:RegisteredDirectOffering237224SharesOfCommonStockMember2024-12-31 0001096275wksp:PrefundedWarrantSharesMemberwksp:RegisteredDirectOffering237224SharesOfCommonStockMember2024-12-31 0001096275wksp:ExercisableWarrantSharesMemberwksp:RegisteredDirectOffering237224SharesOfCommonStockMember2024-12-31 0001096275wksp:PrefundedWarrantTwoSharesMemberwksp:RegisteredDirectOffering237224SharesOfCommonStockMember2024-01-012024-12-31 0001096275wksp:ExercisableWarrantAndPrefundedWarrantsMemberwksp:RegisteredDirectOffering237224SharesOfCommonStockMember2024-01-012024-12-31 0001096275wksp:SaleOfCommonStock95000SharesMember2024-01-012024-12-31 0001096275wksp:CommonStockWarrantSharesMemberwksp:SaleOfCommonStock95000SharesMember2024-01-012024-12-31 0001096275wksp:HolderMember2023-01-012023-12-31 0001096275wksp:ExtendedExercisablePeriodWarrantSharesMemberwksp:HolderMember2023-12-31 0001096275us-gaap:RestrictedStockUnitsRSUMemberwksp:HolderMember2023-01-012023-12-31 0001096275wksp:WarrantExpringFebruary282032Member2026-09-30 0001096275wksp:WarrantExpriringJune132028ToOctober242028Member2026-09-30 0001096275wksp:WarrantExpriringJune132028ToOctober242028Membersrt:MinimumMember2026-09-30 0001096275wksp:WarrantExpriringJune132028ToOctober242028Membersrt:MaximumMember2026-09-30 0001096275wksp:WarrantExpiringSeptember212029Member2026-09-30 0001096275wksp:WarrantExpringMarch22028Member2026-09-30 0001096275wksp:WarrantExpiringMarch220282Member2026-09-30 0001096275wksp:WarrantExpiringDecember312026Member2026-09-30 0001096275srt:WeightedAverageMember2026-09-30 0001096275srt:WeightedAverageMember2025-12-31 0001096275srt:WeightedAverageMember2024-12-31 00010962752025-01-012025-12-31 0001096275wksp:The2015EquityIncentivePlanMember2026-01-012026-09-30 0001096275wksp:The2022EquityIncentivePlanMembersrt:WeightedAverageMember2026-01-012026-09-30 0001096275wksp:The2022EquityIncentivePlanMembersrt:MaximumMember2026-01-012026-09-30 0001096275us-gaap:RestrictedStockUnitsRSUMember2022-11-112022-11-11 0001096275us-gaap:PerformanceSharesMember2021-12-292021-12-29 0001096275srt:ChiefExecutiveOfficerMember2023-05-012023-05-01 0001096275us-gaap:PerformanceSharesMember2022-11-112022-11-11 0001096275us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2022-11-112022-11-11 0001096275us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2022-11-11 0001096275us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2022-11-112022-11-11 0001096275us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2022-11-11 0001096275us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2022-11-112022-11-11 0001096275us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2022-11-11 0001096275us-gaap:PerformanceSharesMember2022-11-11 0001096275us-gaap:PerformanceSharesMember2026-01-012026-09-30 0001096275us-gaap:PerformanceSharesMemberus-gaap:GeneralAndAdministrativeExpense2026-07-012026-09-30 0001096275us-gaap:PerformanceSharesMemberus-gaap:GeneralAndAdministrativeExpense2026-01-012026-09-30 0001096275us-gaap:PerformanceSharesMemberus-gaap:GeneralAndAdministrativeExpense2025-07-012025-09-30 0001096275us-gaap:PerformanceSharesMemberus-gaap:GeneralAndAdministrativeExpense2025-01-012025-09-30 0001096275us-gaap:PerformanceSharesMembersrt:ChiefExecutiveOfficerMember2021-12-292021-12-29 0001096275us-gaap:PerformanceSharesMembersrt:DirectorMember2021-12-292021-12-29 0001096275us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2021-12-292021-12-29 0001096275us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2021-12-29 0001096275us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2021-12-292021-12-29 0001096275us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2021-12-29 0001096275us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2021-12-292021-12-29 0001096275us-gaap:PerformanceSharesMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2021-12-29 0001096275wksp:VariousDirectorsMemberwksp:VestingRatablyOverThreeYearsMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMemberwksp:VariousDirectorsMemberwksp:VestingRatablyOverThreeYearsMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMemberwksp:VariousDirectorsMemberwksp:VestingRatablyOverThreeYearsMember2026-01-012026-09-30 0001096275wksp:VariousEmployeesAndConsultantsMemberwksp:VestingOverOneYearMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMemberwksp:VariousEmployeesAndConsultantsMemberwksp:VestingOverOneYearMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMemberwksp:VariousEmployeesAndConsultantsMemberwksp:VestingOverOneYearMember2026-01-012026-09-30 0001096275wksp:VariousEmployeesAndConsultantsMemberwksp:VestingRatablyOverThreeYearsMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMemberwksp:VariousEmployeesAndConsultantsMemberwksp:VestingRatablyOverThreeYearsMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMemberwksp:VariousEmployeesAndConsultantsMemberwksp:VestingRatablyOverThreeYearsMember2026-01-012026-09-30 0001096275wksp:VariousEmployeesAndConsultantsMemberwksp:VestingPursuantToPerformanceMilestonesMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMemberwksp:VariousEmployeesAndConsultantsMemberwksp:VestingPursuantToPerformanceMilestonesMember2026-01-012026-09-30 0001096275wksp:VariousEmployeesAndConsultantsMemberwksp:VestingRatablyOverTwoYearsMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMemberwksp:VariousEmployeesAndConsultantsMemberwksp:VestingRatablyOverTwoYearsMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMemberwksp:VariousEmployeesAndConsultantsMemberwksp:VestingRatablyOverTwoYearsMember2026-01-012026-09-30 0001096275wksp:VariousEmployeesAndConsultantsMemberwksp:VestingIn12MonthsAndVestingRatablyBetween2ndAnd3rdAnniversaryMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMemberwksp:VariousEmployeesAndConsultantsMemberwksp:VestingIn12MonthsMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMemberwksp:VariousEmployeesAndConsultantsMemberwksp:VestingRatablyBetween2ndAnd3rdAnniversaryMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMemberwksp:VariousEmployeesAndConsultantsMemberwksp:VestingIn12MonthsAndVestingRatablyBetween2ndAnd3rdAnniversaryMember2026-01-012026-09-30 0001096275wksp:VariousEmployeesAndConsultantsMemberwksp:OneHarfVestedAtGrantDateAndOneHalfVestingRatablyOverTwoYearsMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMemberwksp:VariousEmployeesAndConsultantsMemberwksp:VestedAtGrantDateMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMemberwksp:VariousEmployeesAndConsultantsMemberwksp:OneHarfVestedAtGrantDateAndOneHalfVestingRatablyOverTwoYearsMember2026-01-012026-09-30 0001096275srt:ChiefExecutiveOfficerMemberwksp:VestingRatablyOverThreeYearsMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMembersrt:ChiefExecutiveOfficerMemberwksp:VestingRatablyOverThreeYearsMember2026-01-012026-09-30 0001096275wksp:TerravisEnergyIncMemberwksp:LorenzoRossiMemberwksp:VestingAt6MonthsMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMemberwksp:TerravisEnergyIncMemberwksp:LorenzoRossiMemberwksp:VestingAt6MonthsMember2026-01-012026-09-30 0001096275wksp:TerravisEnergyIncMembersrt:ChiefExecutiveOfficerMemberwksp:VestingAt6MonthsMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMemberwksp:TerravisEnergyIncMembersrt:ChiefExecutiveOfficerMemberwksp:VestingAt6MonthsMember2026-01-012026-09-30 0001096275wksp:TerravisEnergyIncMemberwksp:VariousConsultantsMemberwksp:VestingAt6MonthsMember2026-01-012026-09-30 0001096275us-gaap:EmployeeStockOptionMemberwksp:TerravisEnergyIncMemberwksp:VariousConsultantsMemberwksp:VestingAt6MonthsMember2026-01-012026-09-30 0001096275wksp:TerravisEnergyIncMember2025-12-31 0001096275wksp:TerravisEnergyIncMember2024-12-31 0001096275wksp:TerravisEnergyIncMember2026-01-012026-09-30 0001096275wksp:TerravisEnergyIncMember2025-01-012025-12-31 0001096275wksp:TerravisEnergyIncMember2026-09-30 0001096275us-gaap:OperatingSegmentsMemberwksp:HardTonneauCoversMember2026-07-012026-09-30 0001096275us-gaap:OperatingSegmentsMemberwksp:SoftTonneauCoversMember2026-07-012026-09-30 0001096275us-gaap:CorporateNonSegmentMember2026-07-012026-09-30 0001096275us-gaap:OperatingSegmentsMemberwksp:HardTonneauCoversMember2025-07-012025-09-30 0001096275us-gaap:OperatingSegmentsMemberwksp:SoftTonneauCoversMember2025-07-012025-09-30 0001096275us-gaap:CorporateNonSegmentMember2025-07-012025-09-30 0001096275us-gaap:OperatingSegmentsMemberwksp:HardTonneauCoversMember2026-01-012026-09-30 0001096275us-gaap:OperatingSegmentsMemberwksp:SoftTonneauCoversMember2026-01-012026-09-30 0001096275us-gaap:CorporateNonSegmentMember2026-01-012026-09-30 0001096275us-gaap:OperatingSegmentsMemberwksp:HardTonneauCoversMember2025-01-012025-09-30 0001096275us-gaap:OperatingSegmentsMemberwksp:SoftTonneauCoversMember2025-01-012025-09-30 0001096275us-gaap:CorporateNonSegmentMember2025-01-012025-09-30 0001096275wksp:HardTonneauCoversMembercountry:US2026-01-012026-09-30 0001096275wksp:SoftTonneauCoversMembercountry:US2026-01-012026-09-30 0001096275country:US2026-01-012026-09-30 0001096275wksp:HardTonneauCoversMembercountry:US2025-01-012025-09-30 0001096275wksp:SoftTonneauCoversMembercountry:US2025-01-012025-09-30 0001096275country:US2025-01-012025-09-30 0001096275wksp:HardTonneauCoversMembercountry:CA2026-01-012026-09-30 0001096275wksp:SoftTonneauCoversMembercountry:CA2026-01-012026-09-30 0001096275country:CA2026-01-012026-09-30 0001096275wksp:HardTonneauCoversMembercountry:CA2025-01-012025-09-30 0001096275wksp:SoftTonneauCoversMembercountry:CA2025-01-012025-09-30 0001096275country:CA2025-01-012025-09-30 0001096275wksp:HardTonneauCoversMember2026-01-012026-09-30 0001096275wksp:SoftTonneauCoversMember2026-01-012026-09-30 0001096275wksp:HardTonneauCoversMember2025-01-012025-09-30 0001096275wksp:SoftTonneauCoversMember2025-01-012025-09-30 0001096275us-gaap:NetAssetsGeographicAreaMemberus-gaap:GeographicConcentrationRiskMembercountry:US2026-01-012026-09-30 0001096275us-gaap:NetAssetsGeographicAreaMemberus-gaap:GeographicConcentrationRiskMembercountry:US2025-01-012025-12-31 0001096275us-gaap:SubsequentEventMemberwksp:MrStevenRossiMember2026-11-092026-11-09 0001096275us-gaap:SubsequentEventMemberwksp:MrLorenzoRossiMember2026-11-092026-11-09 0001096275us-gaap:SubsequentEventMemberwksp:MrNedSiegelMember2026-11-092026-11-09 0001096275us-gaap:SubsequentEventMemberwksp:MrCraigLoverockMember2026-11-092026-11-09 0001096275us-gaap:SubsequentEventMemberwksp:MrWilliamCaragolMember2026-11-092026-11-09 0001096275us-gaap:SubsequentEventMemberwksp:JenniferKartychakMember2026-11-092026-11-09

 

 

Table of Contents



UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For Quarterly Period Ended: September 30, 2026

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File No. 001-40681

 

Worksport Ltd.

(Exact name of registrant as specified in its charter)

 

Nevada

 

35-2696895

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)

 

Identification No.)

 

2500 N America Dr, West Seneca, NY

 

14224

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s Telephone Number, including area code: (888) 554-8789

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:

 

Trading Symbol(s)

 

Name of each exchange on which registered:

Common Stock

 

WKSP

 

The Nasdaq Stock Market LLC

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes ☒ No ☐

 


Table of Contents

 

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

☐

Accelerated filer

☐

Non-accelerated filer

☒

Smaller reporting company

☒

 

 

Emerging growth company

☐

 

If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

As of November 10, 2026, the Registrant had 20,267,672 shares of common stock, par value $0.001 per share, issued and outstanding.

 



 

 


Table of Contents

 

image01.jpg

QUARTERLY REPORT ON FORM 10-Q

TABLE OF CONTENTS

 

 

Page

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements.

 

Condensed Consolidated Balance Sheets at September 30, 2026 (Unaudited) and December 31, 2025

4

Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2026 and 2025 (Unaudited)

5

Condensed Consolidated Statements of Shareholders’ Equity for the three and nine months ended September 30, 2026 and 2025 (Unaudited)

6

Condensed Consolidated Statements of Cash Flow for the nine months ended September 30, 2026 and 2025 (Unaudited)

8

Notes to the Condensed Consolidated Financial Statements (Unaudited)

9

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

28

 

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

43

 

 

Item 4. Controls and Procedures

43

 

 

PART II OTHER INFORMATION

 

 

 

Item 1. Legal Proceedings

44

 

 

Item 1A. Risk Factors

44

 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

45

 

 

Item 3. Defaults Upon Senior Securities

45

 

 

Item 4. Mine Safety Disclosures

45

 

 

Item 5. Other Information

46

 

 

Item 6. Exhibits

48

 

 

SIGNATURES

49

 

3


Table of Contents

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

image01.jpg

Condensed Consolidated Balance Sheets

(Unaudited)

 

 

 

September 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

 

 

(Unaudited)

 

 

 

 

​

ASSETS

 

 

 

​

 

 

 

​

Current assets

 

 

 

​

 

 

 

​

Cash and cash equivalents

 

$

2,528,222

 

 

$

5,945,894

 

Accounts receivable, net

 

 

1,152,964

 

 

 

503,971

 

Other receivable

 

 

334,794

 

 

 

278,027

 

Inventories, net (Note 3)

 

 

9,583,539

 

 

 

9,530,671

 

Prepaid expenses and other (Note 6)

 

 

462,517

 

 

 

530,861

 

Total current assets

 

 

14,062,036

 

 

 

16,789,424

 

Property and equipment, net (Note 4)

 

 

11,616,967

 

 

 

12,688,488

 

Operating lease right-of-use assets (Note 11)

 

 

189,173

 

 

 

272,598

 

Other noncurrent assets

 

 

300,046

 

 

 

67,033

 

Intangible assets, net (Note 5)

 

 

665,145

 

 

 

896,531

 

Total assets

 

$

26,833,367

 

 

$

30,714,074

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

​

 

 

 

​

Current liabilities

 

 

 

​

 

 

 

​

Accounts payable

 

$

1,971,697

 

 

$

3,107,085

 

Accrued liabilities and other

 

 

1,262,674

 

 

 

1,400,730

 

Accrued compensation

 

 

276,069

 

 

 

420,210

 

Long-term debt, current portion (Note 12)

 

 

1,030,454

 

 

 

1,686,809

 

Lease liability, current portion (Note 11)

 

 

112,960

 

 

 

113,012

 

Total current liabilities

 

 

4,653,854

 

 

 

6,727,846

 

Lease liability, excluding current portion (Note 11)

 

 

76,213

 

 

 

159,526

 

Long-term debt, excluding current portion (Note 12)

 

 

3,283,500

 

 

 

950,481

 

Total liabilities

 

 

8,013,567

 

 

 

7,837,853

 

 

 

 

 

​

 

 

 

​

Shareholders’ equity

 

 

 

​

 

 

 

​

Series A, B and Series C preferred stock, $0.001 par value, 10,000,000 shares authorized, 100 Series A, 0 Series B, and 427,612 and 427,812 Series C issued and outstanding, respectively (Note 7)

 

 

428

 

 

 

428

 

Common stock, $0.001 par value, 45,000,000 shares authorized, 19,993,672 and 9,814,665 shares issued and outstanding, respectively (Note 7)

 

 

19,993

 

 

 

9,814

 

Additional paid-in capital

 

 

114,038,936

 

 

 

101,357,686

 

Share subscriptions receivable

 

 

(1,577

)

 

 

(55,684

)

Share subscriptions payable

 

 

2,119,458

 

 

 

5,446,347

 

Accumulated deficit

 

 

(97,348,858

)

 

 

(83,873,790

)

Cumulative translation adjustment

 

 

(8,580

)

 

 

(8,580

)

Total shareholders’ equity

 

 

18,819,800

 

 

 

22,876,221

 

Total liabilities and shareholders’ equity

 

$

26,833,367

 

 

$

30,714,074

 

 

See accompanying Notes to Condensed Consolidated Financial Statements which form an integral part of the Condensed Consolidated Financial Statements.

 

4


Table of Contents

 

image01.jpg

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

 

 

 

Three Months ended

 

 

Nine Months ended

 

 

 

September 30,

 

 

September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Net sales

 

$

7,228,298

 

 

$

5,013,872

 

 

$

15,770,758

 

 

$

11,358,835

 

Cost of sales

 

 

5,039,591

 

 

 

3,445,088

 

 

 

11,078,169

 

 

 

8,311,718

 

Gross profit

 

 

2,188,707

 

 

 

1,568,784

 

 

 

4,692,589

 

 

 

3,047,117

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Operating expenses

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Research and development

 

 

212,914

 

 

 

301,095

 

 

 

632,429

 

 

 

975,529

 

General and administrative

 

 

3,581,905

 

 

 

3,698,756

 

 

 

11,369,927

 

 

 

10,221,979

 

Sales and marketing

 

 

1,817,563

 

 

 

2,362,195

 

 

 

5,680,624

 

 

 

4,537,299

 

(Gain) loss on foreign exchange

 

 

5,640

 

 

 

(491

)

 

 

1,654

 

 

 

(4,129

)

Total operating expenses

 

 

5,618,022

 

 

 

6,361,555

 

 

 

17,684,634

 

 

 

15,730,678

 

Loss from operations

 

 

(3,429,315

)

 

 

(4,792,771

)

 

 

(12,992,045

)

 

 

(12,683,561

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Other income (expense)

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Interest expense

 

 

(175,243

)

 

 

(138,887

)

 

 

(414,462

)

 

 

(462,481

)

Other

 

 

5,166

 

 

 

2,979

 

 

 

13,290

 

 

 

22,415

 

Total other income (expense)

 

 

(170,077

)

 

 

(135,908

)

 

 

(401,172

)

 

 

(440,066

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Net loss

 

$

(3,599,392

)

 

$

(4,928,679

)

 

$

(13,393,217

)

 

$

(13,123,627

)

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Loss per share (basic and diluted) (Note 13)

 

$

(0.26

)

 

$

(0.75

)

 

$

(1.12

)

 

$

(2.44

)

Weighted average number of shares (basic and diluted)

 

 

13,605,813

 

 

 

6,563,228

 

 

 

11,902,961

 

 

 

5,377,750

 

 

See accompanying Notes to Condensed Consolidated Financial Statements which form an integral part of the Condensed Consolidated Financial Statements.

 

5


Table of Contents

 

image01.jpg

Condensed Consolidated Statements of Shareholders’ Equity

(Unaudited)

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

Additional

 

 

Share

 

 

Share

 

 

 

 

​

 

Cumulative

 

 

Total

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Paid-in

 

 

Subscriptions

 

 

Subscription

 

 

Accumulated

 

 

Translation

 

 

Shareholders’

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Receivable

 

 

Payable

 

 

Deficit

 

 

Adjustment

 

 

Equity

 

Balance at July 1, 2025

 

 

49,435

 

 

$

49

 

 

 

5,519,130

 

 

$

5,518

 

 

$

87,970,432

 

 

$

(1,577

)

 

$

2,022,630

 

 

$

(72,671,914

)

 

$

(8,580

)

 

$

17,316,558

 

Issuance for services and subscriptions payable

 

 

-

 

 

 

-

 

 

 

4,594

 

 

 

5

 

 

 

696,168

 

 

 

-

 

 

 

103,722

 

 

 

-

 

 

 

-

 

 

 

799,895

 

Warrant exercise (Note 14)

 

 

-

 

 

 

-

 

 

 

87,894

 

 

 

88

 

 

 

318,410

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

318,498

 

Issuance of Series C preferred shares pursuant to Reg-A

 

 

2,299,867

 

 

 

2,300

 

 

 

-

 

 

 

-

 

 

 

2,232,233

 

 

 

(188,427

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,046,106

 

Conversion of Series C preferred shares

 

 

(1,977,418

)

 

 

(1,977

)

 

 

1,977,418

 

 

 

1,977

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of warrants pursuant to Reg-A

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

4,566,535

 

 

 

(322,388

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

4,244,147

 

Dividend payable on Series C preferred shareholders (Note 7)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(17,133

)

 

 

-

 

 

 

(17,133

)

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(4,928,679

)

 

 

-

 

 

 

(4,928,679

)

Balance at September 30, 2025

 

 

371,884

 

 

 

372

 

 

 

7,589,036

 

 

 

7,588

 

 

 

95,783,778

 

 

 

(512,392

)

 

 

2,126,352

 

 

 

(77,617,726

)

 

 

(8,580

)

 

 

19,779,392

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Balance at July 1, 2026

 

 

427,712

 

 

$

428

 

 

 

15,282,595

 

 

$

15,282

 

 

$

110,652,344

 

 

$

(1,577

)

 

$

2,140,104

 

 

$

(93,721,747

)

 

$

(8,580

)

 

$

19,076,254

 

Issuance for services and subscriptions payable

 

 

-

 

 

 

-

 

 

 

21,702

 

 

 

22

 

 

 

824,280

 

 

 

-

 

 

 

(20,646

)

 

 

-

 

 

 

-

 

 

 

803,656

 

Shares issued (Note 7)

 

 

-

 

 

 

-

 

 

 

848,954

 

 

 

849

 

 

 

261,899

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

262,748

 

Warrant inducement (Note 14)

 

 

-

 

 

 

-

 

 

 

3,840,421

 

 

 

3,840

 

 

 

2,300,413

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,304,253

 

Warrant exercise (Note 14)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Dividends paid and payable to Series C preferred shareholders (Note 7)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(27,719

)

 

 

-

 

 

 

(27,719

)

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(3,599,392

)

 

 

-

 

 

 

(3,599,392

)

Balance at September 30, 2026

 

 

427,712

 

 

$

428

 

 

 

19,993,672

 

 

$

19,993

 

 

$

114,038,936

 

 

$

(1,577

)

 

$

2,119,458

 

 

$

(97,348,858

)

 

$

(8,580

)

 

$

18,819,800

 

 

6


Table of Contents

 

image01.jpg

Condensed Consolidated Statements of Shareholders’ Equity

(Unaudited)

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

Additional

 

 

Share

 

 

Share

 

 

 

 

​

 

Cumulative

 

 

Total

 

 

 

Preferred Stock

 

 

Common Stock

 

 

Paid-in

 

 

Subscriptions

 

 

Subscription

 

 

Accumulated

 

 

Translation

 

 

Shareholders’

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Receivable

 

 

Payable

 

 

Deficit

 

 

Adjustment

 

 

Equity

 

Balance at January 1, 2025

 

 

100

 

 

$

-

 

 

 

4,016,205

 

 

$

4,016

 

 

$

79,781,674

 

 

$

(1,577

)

 

$

2,115,064

 

 

$

(64,476,966

)

 

$

(8,580

)

 

$

17,413,631

 

Issuance for services and subscriptions payable

 

 

-

 

 

 

-

 

 

 

189,703

 

 

 

190

 

 

 

2,183,652

 

 

 

-

 

 

 

11,288

 

 

 

-

 

 

 

-

 

 

 

2,195,130

 

Shares issued (Note 7)

 

 

-

 

 

 

-

 

 

 

110,619

 

 

 

110

 

 

 

504,262

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

504,372

 

Warrant exercise (Note 14)

 

 

-

 

 

 

-

 

 

 

1,295,091

 

 

 

1,295

 

 

 

6,383,545

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

6,384,840

 

Issuance of Series C preferred shares pursuant to Reg-A

 

 

2,349,202

 

 

 

2,349

 

 

 

-

 

 

 

-

 

 

 

2,247,329

 

 

 

(188,427

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,061,251

 

Conversion of Series C preferred shares

 

 

(1,977,418

)

 

 

(1,977

)

 

 

1,977,418

 

 

 

1,977

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of warrants pursuant to Reg-A

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

4,683,316

 

 

 

(322,388

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

4,360,928

 

Dividend payable on Series C preferred shareholders (Note 7)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(17,133

)

 

 

-

 

 

 

(17,133

)

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(13,123,627

)

 

 

-

 

 

 

(13,123,627

)

Balance at September 30, 2025

 

 

371,884

 

 

 

372

 

 

 

7,589,036

 

 

 

7,588

 

 

 

95,783,778

 

 

 

(512,392

)

 

 

2,126,352

 

 

 

(77,617,726

)

 

 

(8,580

)

 

 

19,779,392

 

 

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Balance at January 1, 2026

 

 

427,912

 

 

$

428

 

 

 

9,814,665

 

 

$

9,814

 

 

$

101,357,686

 

 

$

(55,684

)

 

$

5,446,347

 

 

$

(83,873,790

)

 

$

(8,580

)

 

$

22,876,221

 

Issuance for services and subscriptions payable

 

 

-

 

 

 

-

 

 

 

209,436

 

 

 

210

 

 

 

2,345,960

 

 

 

-

 

 

 

(11,737

)

 

 

-

 

 

 

-

 

 

 

2,334,433

 

Shares issued (Note 7)

 

 

-

 

 

 

-

 

 

 

5,486,950

 

 

 

5,487

 

 

 

4,720,367

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

4,725,854

 

Warrant inducement (Note 14)

 

 

-

 

 

 

-

 

 

 

4,482,421

 

 

 

4,482

 

 

 

5,614,923

 

 

 

-

 

 

 

(3,315,152

)

 

 

-

 

 

 

-

 

 

 

2,304,253

 

Warrant issuance (Note 14)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(105,183

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(105,183

)

Warrant exercise (Note 14)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

105,183

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

105,183

 

Dividends paid and payable to Series C preferred shareholders (Note 7)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(81,851

)

 

 

-

 

 

 

(81,851

)

Proceeds from escrow pursuant to Reg-A

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

54,107

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

54,107

 

Conversions of Series C preferred shares

 

 

(200

)

 

 

-

 

 

 

200

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(13,393,217

)

 

 

-

 

 

 

(13,393,217

)

Balance at September 30, 2026

 

 

427,712

 

 

$

428

 

 

 

19,993,672

 

 

$

19,993

 

 

$

114,038,936

 

 

$

(1,577

)

 

$

2,119,458

 

 

$

(97,348,858

)

 

$

(8,580

)

 

$

18,819,800

 

 

See accompanying Notes to Condensed Consolidated Financial Statements which form an integral part of the Condensed Consolidated Financial Statements.

7


Table of Contents

 

image01.jpg

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

 

 

Nine Months ended

 

 

 

September 30,

 

 

 

2026

 

 

2025

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

​

 

 

 

​

Net loss

 

$

(13,393,217

)

 

$

(13,123,627

)

Adjustments to reconcile net loss to net cash from operating activities:

 

 

 

​

 

 

 

​

Shares, options and warrants issued for services

 

 

2,241,010

 

 

 

2,139,566

 

Depreciation and amortization

 

 

1,266,787

 

 

 

1,359,522

 

Change in operating lease

 

 

60

 

 

 

(19,650

)

 

 

 

(9,885,360

)

 

 

(9,644,189

)

Changes in operating assets and liabilities (Note 10)

 

 

(2,157,676

)

 

 

(1,545,993

)

Net cash provided by (used in) operating activities

 

 

(12,043,036

)

 

 

(11,190,182

)

 

 

 

 

​

 

 

 

​

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

​

 

 

 

​

Purchase of property and equipment

 

 

(206,133

)

 

 

(634,082

)

Purchase of intangible assets

 

 

(68,744

)

 

 

(376,802

)

Purchase of investments

 

 

-

 

 

 

(56,373

)

Net cash provided by (used in) investing activities

 

 

(274,877

)

 

 

(1,067,257

)

 

 

 

 

​

 

 

 

​

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

​

 

 

 

​

Proceeds from issuance of common stock, net of issuance cost

 

 

4,841,885

 

 

 

497,635

 

Proceeds from issuance of preferred stock, net of issuance cost

 

 

105,183

 

 

 

2,082,013

 

Proceeds from issuance of warrants, net of issuance cost

 

 

54,107

 

 

 

4,387,189

 

Proceeds from warrant exercise

 

 

2,304,253

 

 

 

6,384,840

 

Proceeds from line of credit

 

 

17,344,202

 

 

 

8,843,139

 

Repayments on line of credit

 

 

(15,491,833

)

 

 

(10,910,449

)

Repayments on long-term debt

 

 

(175,705

)

 

 

(148,337

)

Dividends paid to Series C Preferred shareholders

 

 

(81,851

)

 

 

-

 

Net cash provided by (used in) financing activities

 

 

8,900,241

 

 

 

11,136,030

 

 

 

 

 

​

 

 

 

​

Increase (decrease) in cash and cash equivalents

 

 

(3,417,672

)

 

 

(1,121,409

)

Cash and cash equivalents - beginning of period

 

 

5,945,894

 

 

 

4,883,099

 

Cash and cash equivalents - end of period

 

$

2,528,222

 

 

$

3,761,690

 

 

 

 

 

​

 

 

 

​

SUPPLEMENTAL CASH FLOW INFORMATION

 

 

 

​

 

 

 

​

Income tax paid

 

$

-

 

 

$

-

 

Interest paid

 

$

392,000

 

 

$

301,000

 

 

 

 

 

​

 

 

 

​

 

 

See accompanying Notes to Condensed Consolidated Financial Statements which form an integral part of the Condensed Consolidated Financial Statements.

 

8


Table of Contents

 

image01.jpg

Notes to the Condensed Consolidated Financial Statements

(Unaudited)

 

Note 1- Description of Business and Significant Accounting Policies

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments consisting of normal recurring adjustments considered necessary for the fair presentation of results for the interim period have been included. The results of operations for the three and nine months ended September 30, 2026 are not necessarily indicative of the results expected for the full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in our Form 10-K for the fiscal year ended  December 31, 2025. All references to years in these financial statements are fiscal years.

 

Reclassifications

 

Certain prior year amounts have been reclassified to conform to the current year’s presentation. The Company reclassified professional fees of $748,656 and $1,812,190 for the three and nine months ended September 30, 2025 from professional fees to general and administrative expense in the condensed consolidated statements of operations and comprehensive loss. This change better aligns the nature of the expenses that support the Company’s administrative efforts. The Company reclassified interest income of $2,979 and $22,415 for the three and nine months ended September 30, 2025 from interest income to other in the condensed consolidated statements of operations and comprehensive loss to conform with current year presentation. The Company reclassified investments of $67,033 at  December 31, 2025 from investment to other noncurrent assets on the condensed consolidated balance sheet to conform with current period presentation.

 

Recent accounting pronouncements

 

Recent accounting pronouncements not yet adopted

 

In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income – Expense Disaggregation Disclosures. This ASU enhances disclosure of specified categories of expenses (purchases of inventory, employee compensation, depreciation and amortization) included in certain expense captions presented on the face of the income statement. ASU 2024-03 is effective for fiscal years beginning after December 15, 2026, and for interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the potential effect that the updated standard will have on the consolidated financial statements and related disclosures.

 

In September 2025, the FASB issued ASU 2025-06, Intangibles – Goodwill and Other-Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. This ASU removes all references to prescriptive and sequential software development stages and will now require public business entities to start capitalizing software costs when management has authorized and committed to funding the software project and is probable that project will be completed and the software will be used to perform the function intended. The ASU also specifies that the disclosures in Subtopic 360-10, Property, Plant and Equipment – Overall, are required for all capitalized internal-use software costs. ASU 2025-06 is effective for fiscal years beginning after December 15, 2027, with early adoption permitted. The Company is currently evaluating the disclosure requirements of this standard and the impact on its consolidated financial statements.

 

9


Table of Contents

 

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270): Narrow Scope Improvements. This ASU amends Topic 270 by improving the navigability of the required interim disclosures and clarifying when the guidance is applicable. The amendment provides additional guidance on when disclosures should be provided in interim reporting periods and requires entities to disclose events since the end of the last annual reporting period that have a material impact on the Company. ASU 2025-11 is effective for interim reporting periods within annual reporting periods beginning after December 15, 2026, with early adoption permitted. The Company is currently evaluating the disclosure requirements of this standard and the impact on its consolidated financial statements.

 

In December 2025, the FASB issued ASU 2025-10, Government Grant (Topic 832): Accounting for Government Grants Received by Business Entities. This ASU establishes authoritative guidance on the recognition, measurement, presentation, and disclosure of government grants. ASU 2025-10 is effective for fiscal years beginning after December 15, 2028, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the disclosure requirements of this standard and the impact on its consolidated financial statements. 

 

The Company considers the applicability and impact of all ASUs. ASUs not listed were assessed and determined to be either not applicable or had or are expected to have an immaterial impact on the consolidated financial statements and related disclosures.

 

Note 2 - Going Concern

 

As of  September 30, 2026, the Company had $2,528,222 in cash and cash equivalents. The Company also had availability on its revolving line of credit of $1,818,887. The Company has generated only limited revenues and has relied primarily upon capital generated from public and private offerings of its securities. Since the Company’s acquisition of Worksport in 2014, it has never generated a profit. As of  September 30, 2026, the Company had an accumulated deficit of $97,348,858.

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates the realization of assets and the liquidation of liabilities in the normal course of business. During the three months ended  September 30, 2026, the Company had net losses of $3,599,392 (2025 - $4,928,679). During the nine months ended September 30, 2026, the Company had net losses of $13,393,217 (2025 - $13,123,627). As of  September 30, 2026, the Company had working capital of $9,408,182 ( December 31, 2025 - $10,061,578) and had an accumulated deficit of $97,348,858 ( December 31, 2025 - $83,873,790). The Company has not generated profit from operations since inception and to date has relied on debt and equity financing for continued operations. The Company’s ability to continue as a going concern is dependent upon the ability to generate cash flows from operations and obtain equity and/or debt financing. The Company intends to continue funding operations through equity and debt financing arrangements, which may be insufficient to fund its capital expenditures, working capital and other cash requirements in the long term. There can be no assurance that the steps management is taking will be successful.

 

The Company has historically operated at a loss, although that may change as sales volumes increase and margins improve. As of  September 30, 2026, the Company had cash and cash equivalents of $2,528,222 ( December 31, 2025 - $5,945,894). Despite the Company having completed its purchasing of large manufacturing machinery for phase one output levels, operational costs are expected to remain elevated and, thus, further decrease cash and cash equivalents. Concurrently, the Company intends to continue its ramp-up of manufacturing and increasing sales volumes in 2026, which should mitigate the effects of operational costs on cash and cash equivalents as it releases new product lines; this view is supported by the fact that the manufacturing facility of the Company was completed for initial production output in 2023 and quickly began improving output and sales beginning in 2024 and continuing into 2026.

 

The Company has successfully raised capital in recent periods and believes it is positioned to do so again if deemed necessary or strategically advantageous.

 

10


Table of Contents

 

On September 30, 2022, the Company entered into an At The Market Offering Agreement (the “ATM Agreement”) with H.C. Wainwright & Co., LLC (“Wainwright”), pursuant to which the Company could offer and sell shares of its common stock having an aggregate offering price of up to $13.0 million through Wainwright as sales agent under the Company’s shelf registration statement on Form S-3 (File No. 333-267696), including the related base prospectus and prospectus supplement dated October 13, 2022. Sales of shares of common stock through Wainwright, if any, were made pursuant to an “at the market offering” as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended. Under the ATM Agreement, Wainwright is entitled to a commission equal to 3.0% of the gross proceeds from shares sold under the ATM Agreement, and the Company also agreed to reimburse Wainwright for certain specified expenses.

 

Because the Company’s public float was below $75.0 million, sales under the ATM Agreement were subject to the limitations of General Instruction I.B.6 of Form S-3. Accordingly, on November 5, 2024 and December 13, 2024, the Company filed prospectus supplements to update the amount of securities then eligible for sale under the ATM Agreement based on the Company’s public float and prior sales during the applicable rolling 12-month period. The Company’s registration statement on Form S-3 (File No. 333-267696) expired on October 13, 2025. Through the expiration date, the Company had sold 872,027 shares of common stock under the ATM Agreement for aggregate gross proceeds of approximately $6,751,381.

 

On November 14, 2025, the Company and Wainwright entered into an amendment to the ATM Agreement in connection with the Company’s new shelf registration statement on Form S-3 (File No. 333-291582). Pursuant to the amended ATM Agreement and the related base prospectus and prospectus supplement dated December 12, 2025, the Company may offer and sell shares of its common stock having an aggregate offering price of up to $4.0 million through Wainwright as sales agent. Because the Company’s public float remains below $75.0 million, sales under the ATM Agreement remain subject to the limitations of General Instruction I.B.6 of Form S-3, which limits the amount of securities the Company may sell in primary offerings during any rolling 12-month period. During the nine months ended September 30, 2026, the Company sold 4,006,728 shares of common stock pursuant to the ATM Agreement for aggregate gross proceeds of $4,496,875, resulting in net proceeds to the Company of approximately $4,357,740 after deducting commissions and offering expenses.

 

On November 2, 2023, the Company consummated a registered direct offering pursuant to which the Company issued 192,500 shares of common stock and 157,500 pre-funded warrants to an institutional investor for a total net proceeds of $4,261,542. Concurrently with the registered direct offering, the Company issued the same institutional investor 700,000 warrants in a private sale. The warrants are exercisable for 700,000 shares of common stock for $13.40 per share six months after issuance and until five and one-half (5.5) years from the issuance date, subject to beneficial ownership limitations as described in the warrants. The Company registered the 700,000 shares of common stock underlying the warrants on a registration statement on Form S-1 (File No. 333-276241) declared effective by the SEC on December 29, 2023.

 

On March 20, 2024, the Company consummated a registered direct offering pursuant to the prospectus supplement dated March 18, 2024 to the Company’s effective shelf registration statement on Form S-3 (File No. 333-267696), pursuant to which the Company issued 237,224 shares of common stock and 147,789 pre-funded warrants to purchase shares of common stock to the same institutional investor as in the Company’s registered direct offering on November 2, 2023, for a total net proceeds of $2,629,083. Concurrently with the registered direct offering, the Company issued the institutional investor 770,026 warrants in a private sale. The warrants became exercisable six months following issuance at an exercise price of $7.40 per share and expire five and one-half years (5.5) from the issuance date, subject to beneficial ownership limitations contained. The Company registered the resale of the 770,026 shares of common stock underlying the warrants pursuant to a registration statement on Form S-1 (File No. 333-278461) which was declared effective by the SEC on April 8, 2024.

 

On May 29, 2024, the Company sent an inducement letter to a shareholder offering an option to exercise their warrants at a reduced exercise price of $5.198 per warrant. In turn, the Company offered the shareholder new warrants to purchase up to 1,295,000 warrant shares with an exercise price of $5.198. The shares had a term of 5.5 years, with a 6-month required holding period.

 

11


Table of Contents

 

On February 27, 2025, the Company entered into a warrant inducement agreement with a shareholder to exercise 755,558 of their 1,295,000 May 2024 Warrants at a price of $5.198 per share. The remaining unexercised 539,442 warrants are included in share subscription payable. In return, the Company issued 1,424,500 new 2025 Inducement Warrants. Each Inducement Warrant has an exercise price of $6.502, will become exercisable six months after issuance, and have a 5.5-year life. Worksport raised approximately $6,731,000 in gross proceeds before fees and expenses, with the funds earmarked for general corporate and working capital purposes.

 

On June 13, 2025, the Company completed the initial closing of its Regulation A offering whereby up to 3,100,000 Units may be sold at an offering price of $3.25 per unit. Each Unit consists of one share of 8% Series C Convertible Preferred Stock, par value $0.001 per share (the “Series C Preferred Stock”) and one warrant for the right to purchase one (1) share of common stock, $0.001 par value with an exercise price of $4.50 per share. The qualified Regulation A offering is expected to generate gross proceeds of $10,000,000. The Company completed the Regulation A offering in October 2025. The Company completed 32 tranches and received proceeds of $9,092,414 (net of issuance cost of $899,997).

 

On December 11, 2025, the Company entered into a warrant inducement agreement (the “Inducement”) with the holder of existing warrants to purchase an aggregate of 2,194,526 shares at a reduced exercise price of $2.90. Pursuant to the Inducement, the exercising holder of the existing warrants received 3,840,421 inducement warrants, and the Company received $6,364,000 from the exercise of the existing warrants. As a result of the inducement and subsequent exercise, the Company determined the incremental fair value provided to the holder from both the adjustment in exercise price of the existing warrants and the fair value of the inducement warrants issued using the Black Scholes model. The total incremental fair value of $4,485,000 is recorded as a non-cash deemed dividend. The proceeds of the warrant inducement and issuance of 916,000 shares of common stock are recorded as additional paid in capital. The obligation to issue the remaining 1,278,526 shares was satisfied during the three months ended March 31, 2026.

 

On June 17, 2026, the Company entered into a securities purchase agreement (the “First Agreement”) with an institutional accredited investor pursuant to which the Company issued and sold, in a registered direct offering, 208,333 shares of common stock and common stock purchase warrants to purchase up to 208,333 shares of common stock at an offering price of $1.20 per unit, with each unit consisting of one share of common stock and one warrant. The shares of common stock and the shares of common stock issuable upon exercise of the warrants were offered pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-291582), filed with the SEC on November 14, 2025 and declared effective on December 12, 2025, and a prospectus supplement dated June 18, 2026 and filed with the SEC on June 18, 2026. The registered direct offering closed on June 18, 2026 and resulted in gross proceeds of $250,000, before deducting placement agent fees and other offering expenses payable by the Company of $65,000.

 

The warrants issued in the June 17, 2026 registered direct offering had an exercise price of $1.50 per share, were immediately exercisable and would have expired on June 17, 2031. The warrants included a cashless exercise feature pursuant to which the holder was entitled to receive 1.4 shares of common stock for each share underlying the warrant being exercised, without payment of the exercise price, resulting in the potential issuance of up to 291,667 shares of common stock upon cashless exercise. The investor immediately exercised the warrants on a cashless basis for 291,667 shares of common stock on June 17, 2026.

 

On June 18, 2026, the Company entered into a second securities purchase agreement (the “Second Agreement”) with the same institutional accredited investor pursuant to which the Company issued and sold, in a separate registered direct offering, 675,529 shares of common stock at an offering price of $0.70 per share. The shares were offered pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-291582), filed with the SEC on November 14, 2025 and declared effective on December 12, 2025, and a prospectus supplement dated June 18, 2026 and filed with the SEC on June 18, 2026. The registered direct offering closed on June 18, 2026 and resulted in gross proceeds of $472,870 before deducting placement agent fees and other offering expenses payable by the Company of $58,643. No warrants or other derivative securities were issued in connection with the offering.

 

12


Table of Contents

 

On August 27, 2026, the Company entered into a warrant inducement agreement (the “Inducement”) with the holder of existing warrants to purchase an aggregate of 3,840,421 shares at a reduced exercise price of $0.60. Pursuant to the Inducement, the exercising holder of the existing warrants received 4,800,526 inducement warrants, and the Company received $2,304,253 from the exercise of the existing warrants. The Company incurred issuance costs payable of approximately $215,000 that are included as a component of both accounts payable and accrued expenses and other on the condensed consolidated balance sheet as of September 30, 2026. As a result of the inducement and subsequent exercise, the Company determined the incremental fair value provided to the holder from both the adjustment in exercise price of the existing warrants and the fair value of the inducement warrants issued using the Black Scholes model. The total incremental fair value of $3,621,879 is recorded as a non-cash deemed dividend. The proceeds of the warrant inducement and issuance of 3,840,421 shares of common stock are recorded as additional paid in capital. 

 

To date, the Company’s primary sources of liquidity consist of net proceeds from public and private securities offerings and cash exercises of outstanding warrants. Management is focused on transitioning towards revenue as its primary source of liquidity by growing existing product offerings as well as the Company’s customer base. The Company cannot give assurance that it can increase its cash balances or limit its cash consumption and thus maintain sufficient cash balances for planned operations or future business developments. Future business development and demands may lead to cash utilization at levels greater than recently experienced. The Company may need to raise additional capital in the future. However, the Company cannot provide assurances it will be able to raise additional capital on acceptable terms, or at all.

 

The Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the consolidated financial statements are issued. Still, certain factors indicate the existence of a material uncertainty that cast substantial doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty. These adjustments could be material.

 

Note 3 - Inventories

 

Inventories, net of reserves, consists of:

 

 

 

September 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

Raw materials

 

$

5,221,387

 

 

$

5,405,618

 

Finished goods

 

 

3,603,595

 

 

 

3,368,509

 

Work in progress

 

 

758,557

 

 

 

756,544

 

Inventories, net

 

$

9,583,539

 

 

$

9,530,671

 

 

13


Table of Contents

 

Note 4 - Property and Equipment

 

Property and equipment consists of:

 

 

 

September 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

Building

 

$

6,079,410

 

 

$

6,079,410

 

Manufacturing equipment

 

 

6,338,791

 

 

 

6,519,571

 

Land

 

 

2,239,405

 

 

 

2,239,405

 

Leasehold improvements

 

 

512,872

 

 

 

489,722

 

Product molds

 

 

524,476

 

 

 

524,476

 

Warehouse equipment

 

 

567,060

 

 

 

503,297

 

Electrical equipment

 

 

183,977

 

 

 

183,977

 

Automobile

 

 

242,642

 

 

 

242,642

 

Furniture

 

 

149,883

 

 

 

149,883

 

Computers

 

 

101,058

 

 

 

101,058

 

Property and equipment, at cost

 

 

16,939,574

 

 

 

17,033,441

 

Less accumulated depreciation

 

 

(5,322,607

)

 

 

(4,344,953

)

Property and equipment, net

 

$

11,616,967

 

 

$

12,688,488

 

 

On  June 30, 2026, the Company amended an agreement whereby it was released from an outstanding contractual obligation of approximately $2.7 million and outstanding duties payable of $0.3 million related to the acquisition of manufacturing equipment valued with a cost of approximately $3.0 million. Equipment deposits paid totaling $300,000 are included as a component of other noncurrent assets, pursuant to the terms of the amendment. 

 

Depreciation expense for the three months ended  September 30, 2026 and 2025 was $324,578 and $374,195, respectively. Depreciation expense for the nine months ended September 30, 2026 and 2025 was $977,654 and $1,070,145, respectively.

 

Note 5 - Intangible Assets

 

Intangible assets consist of costs incurred to establish the patent rights related to the quick latch and soft vinyl quad-fold tonneau cover technologies, Worksport trademarks, licenses, and software costs. The Company’s utility patents and design registrations were issued between 2014 and 2026. The patents and software are amortized on a straight-line basis over their useful life. The Company’s trademark, licenses, and other indefinite life intangible assets are reassessed every year for impairment. The Company determined that impairment is not necessary for the prior year ended  December 31, 2025 and for the three and nine months ended September 30, 2026.

 

The components of intangible assets are as follows:

 

 

 

September 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

Software

 

$

1,193,244

 

 

$

1,150,000

 

License

 

 

243,829

 

 

 

218,329

 

Patent

 

 

62,706

 

 

 

62,706

 

Trademark

 

 

5,150

 

 

 

5,150

 

Other

 

 

232,772

 

 

 

243,769

 

Intangible assets, gross carrying amount

 

 

1,737,701

 

 

 

1,679,954

 

Less accumulated amortization

 

 

(1,072,556

)

 

 

(783,423

)

Intangible assets, net

 

$

665,145

 

 

$

896,531

 

 

Amortization expense for the three months ended  September 30, 2026 and 2025 was $96,459 and $96,459, respectively. Amortization expense for the nine months ended September 30, 2026 and 2025 was $289,133 and $289,377, respectively.

 

14


Table of Contents

 

Estimated amortization of the patent and software over the next five calendar years and beyond  September 30, 2026 is as follows:

 

2026

 

$

98,000

 

2027

 

$

12,000

 

2028

 

$

12,000

 

2029

 

$

12,000

 

2030

 

$

12,000

 

Thereafter

 

$

37,000

 

 

Note 6 - Prepaid Expenses and Other

 

Prepaid expenses and other consists of:

 

 

 

September 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

Consulting, services and advertising

 

$

175,525

 

 

$

222,922

 

Insurance

 

 

108,865

 

 

 

104,421

 

Deposits

 

 

178,127

 

 

 

203,518

 

Prepaid expenses and other

 

$

462,517

 

 

$

530,861

 

 

Note 7- Shareholders’ Equity

 

The Company is authorized to issue up to 55,000,000 shares of capital stock, par value $0.001 per share. Capital stock is divided into two classes designated as common stock and preferred stock.

 

Common stock – The Company is authorized to issue up to 45,000,000 shares of common stock.

 

Preferred stock – The Company is authorized to issue up to 10,000,000 shares of preferred stock. The board of directors may authorize, without further shareholder action, the issuance of preferred stock in one or more classes or series. Preferred stock ranks senior to common stock with respect to payment of dividends and the distribution of assets on liquidation. Each class or series of preferred stock, when issued, must include its designation and a description of certain rights, including voting privileges, dividend preferences, conversion features, restrictions and redemption rights.

 

 

-

During 2019, the Company created and issued 100 shares of its Series A preferred stock. Series A preferred shareholders vote together as a single class and are entitled to 51% of the voting rights on all matters regardless of the number of Series A preferred shares outstanding. Series A preferred stock does not have conversion rights, is not entitled to receive dividends nor receive any liquidation preferences.

 

-

During 2020, the Company created the Series B preferred stock. Series B preferred shareholders have the right to vote for each share of common stock outstanding after the issuance date. Series B preferred stock does not have conversion rights, is not entitled to receive dividend preferences nor receive any liquidation preferences. As of  September 30, 2026, the Company has not issued shares of Series B preferred stock.

 

-

During 2025, the Company created its Series C preferred stock for its Regulation A offering. Refer to Note 14, Warrants, for a description of units available in the Regulation A offering. Series C preferred stock ranks senior to common stock and future classes or series of preferred stock as to dividend and liquidation rights. Series C preferred shareholders may convert holdings on a 1:1 basis to common stock at any time. Series C preferred shareholders are entitled to cumulative dividends at a rate of 8.00% of the $3.25 liquidation preference per share per year for a period of two (2) years from the date of issuance. As of  September 30, 2026, the Company issued 3,074,586 shares of Series C preferred stock and converted 2,646,974 Series C preferred shares to common stock at the shareholder’s request. The Company recognized dividends payable to Series C preferred shareholders for the three months ended  September 30, 2026 of $27,719.

 

15


Table of Contents

 

During nine months ended September 30, 2026, the following transactions occurred:

 

During the nine months ended September 30, 2026, the Company sold an aggregate of 4,006,728 shares of its common stock pursuant to the ATM Agreement for aggregate gross proceeds of $4,496,875, net of issuance costs of $139,135. The shares in a shelf takedown from the Company were sold pursuant to the base prospectus and prospectus supplement filed with the Securities and Exchange Commission as part of the Company’s registration statement on Form S-3 (File No. 333-291582), which was declared effective on December 12, 2025.

 

The Company recognized consulting expense of $165,534 for share subscriptions payable from restricted shares to be issued. As of  September 30, 2026, 53,325 restricted shares have been issued and $110,880 have not been issued. The Company recognized salary expense of $61,740 for share subscriptions payable from restricted shares to be issued. As of  September 30, 2026, $61,740 have not been issued. The Company also recognized consulting expense of $107,833 related to warrants. As of  September 30, 2026, the warrants vested and were issued. Transactions reflected in salary expense and consulting expense are included as a component of general and administrative expense in the Condensed Consolidated Statements of Operations and Comprehensive Loss.

 

Refer to Note 14, Warrants, and Note 15, Equity Compensation, for additional disclosures related to shareholders’ equity.

 

During nine months ended September 30, 2025, the following transactions occurred:

 

During the nine months ended September 30, 2025, the Company sold an aggregate of 110,619 shares of its common stock pursuant to an At the Market Offering Agreement, dated September 30, 2022, for aggregate gross proceeds of $519,971, net of issuance costs of $15,599. The shares were sold pursuant to the Company’s base prospectus and the related prospectus supplements filed with the Securities and Exchange Commission as part of the Company’s registration statement on Form S-3 (File No. 333-267696), which was declared effective on October 13, 2022.

 

The Company recognized consulting expense of $13,000 and marketing expense of $97,250 to share subscriptions payable from restricted shares and stock options to be issued. As of  September 30, 2025, $110,250 of restricted shares have not been issued. Transactions reflected in consulting expense are included as a component of general and administrative expense in the Condensed Consolidated Statements of Operations and Comprehensive Loss. During the nine months ended September 30, 2025, the Company issued 94,670 restricted shares with a value of $465,100.

 

During the nine months ended September 30, 2025, in connection with the inducement of 1,295,091 warrants at $5.198 per share, the Company also sold 1,424,500 warrants exercisable at $6.502 per share. The Company received proceeds of $6,731,410 before deducting placement agent fees of $346,570 and other offering expenses payable by the Company upon the exercise of the May 2024 Existing Warrants.

 

During the nine months ended September 30, 2025, in connection with the Regulation A offering of up to 3,100,000 Units at an offering price of $3.25 per Unit, the Company issued 2,349,202 Units, received proceeds of $6,469,202 (net of issuance costs of $665,905), and recognized share subscriptions receivable of $458,720 (net of issuance costs of $41,130).

 

During the nine months ended September 30, 2025, certain Series C preferred shareholders converted 1,977,418 shares into the Company's common stock.

 

16


Table of Contents

 

Note 8 - Income Taxes

 

The effective tax rate for the three and nine months ended September 30, 2026 and 2025 was 22.9% before 100% allowance adjustments on net deferred income tax assets. The effective tax rate for the three and nine months ended September 30, 2026 and 2025 was higher than expected from applying the U.S. federal statutory rate of 21% to loss before income taxes due to tax benefits on losses generated outside the U.S. with higher statutory rates.

 

Note 9 - Financial Instruments and Fair Value

 

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an ordinary transaction between market participants at the measurement date. Depending on the nature of the asset or liability, various techniques and assumptions can be used to estimate fair value. The definition of the fair value hierarchy is as follows:

 

Level 1 – Quoted prices in active markets for identical assets and liabilities.

 

Level 2 – Observable inputs other than quoted prices in active markets for similar assets and liabilities.

 

Level 3 – Inputs for which significant valuation assumptions are unobservable in a market and therefore value is based on the best available data, some of which is internally developed and considers risk premiums that a market participant would require.

 

The Company’s financial instruments include cash and cash equivalents, accounts receivable, accounts payable, revolving line of credit, and long-term debt. The fair values of cash and cash equivalents, accounts receivable, and accounts payable approximate their carrying value because of the short-term nature of these instruments. The Company’s revolving line of credit and long-term debt are based on a variable interest rate, and are reflected in the financial statements at carrying value which approximates fair value at  September 30, 2026. The fair value of the revolving line of credit and long-term debt is classified as Level 2 within the fair value hierarchy.

 

The Company is exposed to market risks such as fluctuation in foreign currency exchange rates and interest rates. Derivative instruments may be used to offset some of the effects of these market risks on the expected future cash flows and on certain existing assets and liabilities. The Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures.

 

17


Table of Contents

 

Market Risks

 

Foreign Currency Risk

 

The Company is exposed to currency risk on its sales and purchases denominated in Canadian Dollars. The Company actively manages these risks by adjusting its pricing to reflect currency fluctuations and purchasing foreign currency at advantageous rates.

 

Interest Rate Risk

 

The borrowing under the Company’s Line of Credit Facility and Equipment Financing is at variable interest rates and exposes the Company to interest rate risk. If interest rates increase, debt service obligations on variable rate indebtedness will increase even though the amount borrowed may not change.

 

Note 10 - Changes in Cash Flows from Operating Assets and Liabilities

 

The changes to the Company’s operating assets and liabilities for the nine months ended September 30, 2026 and 2025 are as follows:

 

 

 

2026

 

 

2025

 

Decrease (increase) in accounts receivable

 

$

(648,993

)

 

$

(472,485

)

Decrease (increase) in other receivable

 

 

(56,767

)

 

 

(39,974

)

Decrease (increase) in inventory

 

 

(52,868

)

 

 

(1,645,437

)

Decrease (increase) in prepaid expenses and other

 

 

68,344

 

 

 

(865,634

)

Increase (decrease) in accounts payable and accrued liabilities

 

 

(1,467,392

)

 

 

1,477,537

 

 

 

$

(2,157,676

)

 

$

(1,545,993

)

 

Note 11 - Leases

 

The Company accounts for leases under ASC 842, whereby it recognizes a lease liability and a right-of-use asset. The lease liability is measured at the present value of the remaining lease payments, discounted by the Company’s incremental borrowing rate. The Company measured the right of use asset at an initial amount equal to the lease liability.

 

On April 1, 2025, the Company signed a lease agreement for 12,500 square feet of office space to be used as a R&D facility pursuant to a three-year lease with an option to extend the lease for an additional two years. The lease was effective on May 1, 2025 at a rate of $9,659 per month with a termination date of April 30, 2028. The Company’s incremental borrowing rate used to initially measure the present value of the remaining lease payments was 15%.

 

On July 14, 2025, the Company signed a lease agreement for 1,992 square feet of office space to be used as an R&D facility for its Terravis Energy subsidiary pursuant to a two-year lease effective July 18, 2025 for an average monthly rent of $3,154. The Company’s incremental borrowing rate used to initially measure the present value of the remaining lease payments was 15%.

 

18


Table of Contents

 

The Company’s right-of-use asset and lease liability as of  September 30, 2026, and  December 31, 2025, are as follows:

 

 

 

September 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

Right-of-use asset

 

$

189,173

 

 

$

272,598

 

Current lease liability

 

$

112,960

 

 

$

113,012

 

Long-term lease liability

 

$

76,213

 

 

$

159,526

 

 

The following is a summary of the Company’s total lease costs during the nine months ended September 30, 2026 and 2025:

 

 

 

September 30,

 

 

September 30,

 

 

 

2026

 

 

2025

 

Operating lease cost

 

$

109,000

 

 

$

230,000

 

 

The following is a summary of cash paid during the nine months ended September 30, 2026 and 2025 for amounts included in the measurement of lease liabilities:

 

 

 

September 30,

 

 

September 30,

 

 

 

2026

 

 

2025

 

Operating cashflow

 

$

109,000

 

 

$

230,000

 

 

The following are future calendar year minimum lease payments as of  September 30, 2026:

 

2026

 

$

35,865

 

2027

 

 

134,284

 

2028

 

 

39,784

 

Total future minimum lease payments

 

 

209,933

 

Less: amount representing interest

 

 

(20,760

)

Present value of future payments

 

 

189,173

 

Current portion

 

 

112,960

 

Long term portion

 

$

76,213

 

 

19


Table of Contents

 

Note 12 - Indebtedness

 

Long-term debt consists of:

 

 

 

September 30,

 

 

December 31,

 

 

 

2026

 

 

2025

 

Revolving Credit Facility (a)

 

$

3,283,500

 

 

$

1,441,665

 

Other (b)

 

 

1,045,488

 

 

 

1,233,493

 

 

 

 

4,328,988

 

 

 

2,675,158

 

Deferred debt issuance cost

 

 

(15,034

)

 

 

(37,868

)

Less current installments

 

 

(1,030,454

)

 

 

(1,686,809

)

Long-term debt

 

$

3,283,500

 

 

$

950,481

 

 

 

a)

On July 19, 2024, the Company, as the guarantor, and Worksport New York Operations Corporation as well as Worksport USA Operations Corporation, entered into a $6,000,000 Revolving Financing and Assignment Agreement (the “Agreement”) with an external lending entity with a maturity date of July 18, 2026, or 24 months. The Agreement includes an autorenewal provision whereby the Agreement renews and extends for an additional 24 months at the time of original maturity, or until July 18, 2028. On July 18, 2026, the Agreement was renewed pursuant to the autorenewal provision and now matures on July 18, 2028.

 

 

 

 

 

For collateral, the lender holds a first position on the Company’s major asset classes (accounts receivable, the factory in New York, and inventory) other than the Company’s equipment. A non-usage fee of 0.25% is assessed quarterly and applied to the difference between the quarter’s average daily outstanding loan balance and the total credit facility amount. As of  September 30, 2026, the Company had an available balance of $1,818,887 to borrow under the Agreement.

 

 

 

 

b)

On September 4, 2024, the Company, through its wholly owned subsidiary, Worksport USA Operations Corporation, entered into a $1,487,200 credit and security agreement with an external lending entity with a final maturity date of September 1, 2027, which is 36 months from initial funding. Upon transaction close, the Company received net proceeds of $1,412,750 (net of issuance costs of $43,735). The Company and its wholly owned subsidiary, Worksport New York Operations Corporation, serve as guarantors on the loan. For collateral, the lender holds a first position on the Company’s equipment, which is primarily manufacturing and warehousing equipment. Interest on the loan is based on the prime rate plus 700 basis points per annum. At  September 30, 2026, the outstanding balance of this loan was $1,045,488 (net of issuance costs of $15,034). 

 

The Company is in compliance with all covenants.

 

20


Table of Contents

 

Note 13 - Loss per Share

 

For the three and nine months ended September 30, 2026, loss per share is ($0.26) and ($1.12) (basic and diluted) using the weighted average number of shares of 13,605,813 and 11,902,961 (basic and diluted), respectively. For the three and nine months ended September 30, 2025, loss per share is ($0.75) and ($2.44) (basic and diluted) using the weighted average number of shares of 6,563,228 and 5,377,750 (basic and diluted), respectively.

 

There are 45,000,000 common shares authorized with 19,993,672 and 7,589,036 shares issued and outstanding, at  September 30, 2026 and 2025, respectively. The computation of loss per share is based on the weighted average number of shares outstanding during the period in accordance with ASC Topic No. 260, “Earnings Per Share.” Shares underlying the Company’s outstanding stock options, warrants, preferred stock units and convertible Series C preferred stock were excluded due to the anti-dilutive effect they would have on the computation.

 

Note 14 - Warrants

 

On August 27, 2026, the Company entered into a warrant inducement agreement with the holder of existing warrants to purchase an aggregate of 3,840,421 shares at a reduced exercise price of $0.60. Pursuant to the inducement, the existing holder of the existing warrants received 4,800,526 inducement warrants, and the Company received $2,304,253 from the exercise of the existing warrants. As a result of the inducement and subsequent exercise, the Company determined the incremental fair value provided to the holder from both the adjustment in exercise price of the existing warrants and the fair value of the inducement warrants issued using the Black Scholes model. The total incremental value of $3,621,879 is recorded as a non-cash deemed dividend as a reduction of additional paid-in capital based on the Company’s history of net operating losses. The proceeds of the warrant inducement and issuance of 3,840,421 shares of common stock are recorded as additional paid-in capital. During August 2026, the Company partially satisfied its obligation to issue 3,582,421 shares of common stock. During September 2026, the Company satisfied its remaining obligation to issue 258,000 shares of common stock. Shares subsequently issued after the inducement agreement are recorded as additional paid-in capital.

 

On June 17, 2026, the Company entered into a Securities Purchase Agreement with an accredited investor. The terms of the agreement provided for the issuance of 208,333 units at a price of $1.20 per unit. Each unit consisted of one share of common stock with a par value of $0.001 per share and one warrant to purchase one share of common stock, par value $0.001 per share, at an exercise price of $1.50 per share. The warrants were immediately exercisable and expire on June 17, 2031. The warrants contained a cashless feature, in which the holder was entitled to receive 1.4 shares of common stock for each warrant exercised without transfer of cash. The Company determined the fair value provided to the investor at the date of the agreement using the Black-Scholes model. The investor immediately exercised the cashless feature of the warrants on June 17, 2026.

 

On December 11, 2025, the Company entered into a warrant inducement agreement with the holder of existing warrants to purchase an aggregate of 2,194,526 shares at a reduced exercise price of $2.90. Pursuant to the inducement, the existing holder of the existing warrants received 3,840,421 inducement warrants, and the Company received $6,364,000 from the exercise of the existing warrants. As a result of the inducement and subsequent exercise, the Company determined the incremental fair value provided to the holder from both the adjustment in exercise price of the existing warrants and the fair value of the inducement warrants issued using the Black Scholes model. The total incremental value of $4,485,000 is recorded as a non-cash deemed dividend as a reduction of additional paid-in capital based on the Company’s history of net operating losses. The proceeds of the warrant inducement and issuance of 916,000 shares of common stock are recorded as additional paid-in capital. During December 2025, the Company partially satisfied its obligation to issue 636,526 shares of common stock. During January 2026, the Company satisfied its remaining obligation to issue 642,000 shares of common stock. Shares subsequently issued after the inducement agreement are recorded as additional paid-in capital.

 

21


Table of Contents

 

On September 2, 2025, the Company entered into a consulting agreement with a third party to perform certain services for a six-month period in exchange for both cash consideration and the issuance of warrants. The warrant agreement was issued on March 2, 2026 and is exercisable to purchase up to 100,000 shares for $4.00 per share and 100,000 shares of common stock at $5.00 per share. The warrants expire two years from the date of issuance. The Company determined the fair value provided to the holder at the date of the consulting agreement using the Black-Scholes model, as the warrants were earned by the holder over the term of the consulting agreement. For the fiscal year ended  December 31, 2025, the Company recognized $216,000 as a component of general and administrative expense. For the nine months ended September 30, 2026, the Company recognized $108,000 as a component of general and administrative expense.

 

The Company commenced its Regulation A offering pursuant to which it offered up to 3,100,000 units at a price of $3.25 per unit. Each unit consisted of one share of 8% Series C Convertible Preferred Stock, par value $0.001 per share (the “Series C Preferred Stock”), and one warrant to purchase one share of common stock, par value $0.001 per share, at an exercise price of $4.50 per share. 

 

On June 13, 2025, the Company completed the initial closing of the Regulation A offering. On October 15, 2025, the Company completed the Regulation A offering, pursuant to which it sold an aggregate of 3,074,587 units for gross proceeds of approximately $9.99 million, before deducting fees and expenses. The proceeds from the Regulation A offering are recorded as additional paid-in capital. Through  September 30, 2026, the Company issued 3,074,586 warrants to investors. During the nine months ended September 30, 2026, the Company received $54,107 of previously escrowed proceeds related to the Regulation A offering.

 

On February 27, 2025, the Company entered into a warrant inducement agreement (the “Inducement Agreement”) with the holder of existing warrants to purchase an aggregate of 1,295,000 shares for a reduced exercise price of $5.198 per share. Pursuant to the Inducement Agreement, the exercising holder of the existing warrants received 1,424,500 inducement warrants, and the Company received $6,731,000 from the exercise of the existing warrants, before deducting placement agent fees and other offering expenses payable by the Company. As a result of the inducement and subsequent exercise, the Company determined the incremental fair value provided to the holder from the inducement warrants issued using the Black Scholes model. The total incremental fair value of $7,602,000, is recorded as a non-cash deemed dividend. The proceeds of the warrant inducement and issuance of 1,295,000 shares of common stock are recorded as additional paid-in capital. The Company registered the shares of common stock issuable upon the exercise of the inducement warrants on a registration statement on Form S-1 (File No. 333-286255) declared effective by the Securities and Exchange Commission on April 3, 2025.

 

During the year ended December 31, 2024, in connection with the sale of 237,224 shares of common stock, the Company also sold 147,789 pre-funded warrants and issued 770,026 warrants exercisable for a total of 770,026 shares of common stock for $0.001 and $7.40, respectively, per share. The Company received net proceeds of $1,093,492 associated with the sale of the pre-funded warrants. The pre-funded warrants are immediately exercisable until all of the pre-funded warrants are exercised. During the same period, 147,789 pre-funded warrants were exercised for 147,789 shares of common stock for $150.

 

During the year ended December 31, 2024, the Company closed a sale of 95,000 shares of common stock. In connection with the sale of common stock, the Company issued 190,000 warrants. The warrants have an exercise price of $4.00 and an expiration date of September 21, 2029.

 

During the year ended December 31, 2023, the Company and a stock options holder agreed to cancel all 40,000 stock options in exchange for extending the exercisable period of 30,000 warrants to December 31, 2024. Later in the year ended December 31, 2023, the expiration date for these warrants was extended to December 31, 2026, and the stock option holder was issued an additional 40,000 restricted stock units.

 

22


Table of Contents

 

As of  September 30, 2026, the Company has the following warrants outstanding:

 

 

 

​

 

 

 

​

 

Remaining

 

 

Exercise

 

 

Number

 

 

Contractual

 

 

price

 

 

outstanding

 

 

Life (Years)

 

Expiry date

$

0.60

 

 

 

4,800,526

 

 

 

5.42

 

February 28, 2032

$

4.50

 

 

 

3,074,587

 

 

 

1.70 - 2.07

 

June 13, 2028 – October 24, 2028

$

4.00

 

 

 

190,000

 

 

 

2.98

 

September 21, 2029

$

4.00

 

 

 

100,000

 

 

 

1.42

 

March 2, 2028

$

5.00

 

 

 

100,000

 

 

 

1.42

 

March 2, 2028

$

40.00

 

 

 

30,000

 

 

 

0.25

 

December 31, 2026

 

 

​

 

 

8,295,113

 

 

 

3.94

 

 

 

The average remaining contractual life of outstanding warrants that expire is 2.36 years.

 

 

 

September 30, 2026

 

 

December 31, 2025

 

 

 

Number of

 

 

Weighted

 

 

Number of

 

 

Weighted

 

 

 

warrants

 

 

average price

 

 

warrants

 

 

average price

 

Balance, beginning of year

 

 

7,335,008

 

 

$

3.85

 

 

 

2,291,276

 

 

$

6.35

 

Issuance

 

 

5,092,193

 

 

$

0.65

 

 

 

8,539,508

 

 

$

4.16

 

Expired

 

 

-

 

 

$

-

 

 

 

(6,250

)

 

$

24.00

 

Exercise

 

 

(4,132,088

)

 

$

(0.66

)

 

 

(3,489,526

)

 

$

6.22

 

Balance, end of period

 

 

8,295,113

 

 

$

2.36

 

 

 

7,335,008

 

 

$

3.85

 

 

Note 15 - Equity Compensation 

 

The Company has adopted three equity incentive plans: the 2015 Equity Incentive Plan, the 2021 Equity Incentive Plan, and the 2022 Equity Incentive Plan. The 2015 Equity Incentive Plan expired in 2025 upon reaching the end of its ten-year term. The 2015 and 2021 plans each authorized a fixed number of shares for issuance. Under the 2022 Equity Incentive Plan, the number of shares of common stock reserved for issuance shall not exceed 18% of the issued and outstanding shares of common stock of the Company. Awards under each plan have a maximum term of 10 years and vest at the discretion of the Board of Directors.

 

All equity-settled, share-based payments are ultimately recognized as an expense in the statement of operations with a corresponding credit to “Additional Paid-in Capital.” If vesting periods or other non-market vesting conditions apply, the expense is allocated over the vesting period, based on the best available estimate of the number of share options expected to vest. Estimates are subsequently revised if there is any indication that the number of share options expected to vest differs from previous estimates. Any cumulative adjustment prior to vesting is recognized in the current period. No adjustment is made to any expense recognized in prior periods if share options ultimately exercised are different than that estimated on vesting.

 

Performance Share Units

 

On May 1, 2023, the Company and Steven Rossi reached an agreement to modify 160,000 restricted stock units and 40,000 performance stock units (“PSUs”) issued on November 11, 2022, and December 29, 2021, respectively, and replace them with 200,000 stock options, as described below.

 

23


Table of Contents

 

On November 11, 2022, 40,000 and 30,000 PSUs granted on December 29, 2021, as described below, were modified to include new terms pertaining to the PSU vesting schedule. The PSUs vest in 5% increments according to the modified schedule that correlates with the Company’s stock price. The first 5% of the PSUs vest upon the Company’s stock price closing at $22.50, 50% will have vested at a closing price of $53.10, and 100% will have vested at a closing price of $137.60 as measured using the volume weighted average of the Company’s common stock for ten (10) consecutive trading days, with over $100,000 of trading volume on each of those days. The fair value of the PSUs was estimated to be $1,254,460. As of  September 30, 2026, 7,500 PSUs of the remaining 30,000 PSUs had vested, and the Company recognized $26,881 and $80,643 for the three and nine months ended September 30, 2026 ($26,881 and $80,643 for the three and nine months ended September 30, 2025) in general and administrative expense.

 

On December 29, 2021, the Company granted 40,000 and 30,000 PSUs to the Company’s Chief Executive Officer and a director, respectively. The PSUs were to vest in 5% increments according to a schedule that correlates with the Company’s stock price. The first 5% of the PSUs was to have vested upon the Company’s stock price closing at $30.00; 50% was to have vested at a closing price of $165.00, and 100% was to have vested at a closing price of $315.00. The fair value of the PSUs was estimated to be $1,344,570.

 

Stock Options

 

The Company uses the Black-Scholes option pricing model to determine fair value of stock options on the grant date.

 

During the nine months ended September 30, 2026, the Company issued the following stock options to various directors:

 

 

-

90,006 stock options vesting ratably over three years, with an exercise price of $1.66 and an expiration date of  February 9, 2036

 

During the nine months ended September 30, 2026, the Company issued the following stock options to various employees and consultants:

 

 

-

205,000 stock options vesting over one year, with an exercise price of $2.21 and an expiration date of  January 5, 2036

 

 

 

 

-

75,000 stock options vesting ratably over three years, with an exercise price of $2.21 and an expiration date of  January 5, 2036

 

 

 

 

-

25,000 stock options vesting pursuant to performance milestones, with an exercise price of $2.21 and an expiration date of  January 5, 2036

 

 

 

 

-

15,000 stock options vesting ratably over two years, with an exercise price of $1.66 and an expiration date of  February 9, 2036

 

 

 

 

-

454,050 stock options with one quarter cliff vesting in twelve months and three quarters vesting ratably between the second and third anniversary of the grant date, with an exercise price of $0.63 and an expiration date of  July 31, 2036

 

 

 

 

-

25,500 stock options with one half vested at the grant date and the remaining stock options vesting ratably over two years, with an exercise price of $0.63 and an expiration date of  July 31, 2036

 

24


Table of Contents

 

During the nine months ended September 30, 2026, the Company issued the following stock options to Steven Rossi:
 

 

-

240,000 stock options vesting ratably over three years, with an exercise price of $1.66, and an expiration date of  February 9, 2036

 

 

 

September 30, 2026

 

 

December 31, 2025

 

 

 

Number of

 

 

Weighted

 

 

Number of

 

 

Weighted

 

 

 

stock

 

 

average

 

 

stock

 

 

average

 

 

 

options

 

 

price

 

 

options

 

 

price

 

Balance, beginning of year

 

 

1,171,706

 

 

$

5.37

 

 

 

579,936

 

 

$

7.14

 

Granted

 

 

1,129,556

 

 

$

1.38

 

 

 

596,040

 

 

$

3.68

 

Forfeited

 

 

(1,000

)

 

$

3.09

 

 

 

(4,270

)

 

$

9.52

 

Balance, end of period

 

 

2,300,262

 

 

$

3.41

 

 

 

1,171,706

 

 

$

5.37

 

 

 

 

Range of

 

 

 

 

​

 

Weighted

 

 

Weighted

 

 

Exercisable on

 

 

 

Exercise

 

 

 

 

​

 

average

 

 

average

 

 

September 30,

 

 

 

prices

 

 

Outstanding

 

 

life (years)

 

 

exercise price

 

 

2026

 

Stock options

 

 

$0.63 - $7.04

 

 

 

2,300,262

 

 

 

8.49

 

 

$

3.41

 

 

 

749,879

 

 

During the nine months ended September 30, 2026, Terravis Energy Inc., a majority owned subsidiary of the Company, issued the following stock options:

 

 

-

595,087 stock options to Lorenzo Rossi cliff vesting at six months, with an exercise price of $0.07, and an expiration date of  July 27, 2036

 

-

172,082 stock options to Steven Rossi cliff vesting at six months, with an exercise price of $0.07, and an expiration date of July 27, 2036

 

-

1,346,164 stock options to various consultants cliff vesting at 6 months, with an exercise price of $0.07, and an expiration date of July 27, 2036


 As of  September 30, 2026 and  December 31, 2025, Terravis Energy Inc. has the following options outstanding:

 

 

 

September 30, 2026

 

 

December 31, 2025

 

 

 

Number of

 

 

Weighted

 

 

Number of

 

 

Weighted

 

 

 

stock

 

 

average

 

 

stock

 

 

average

 

 

 

options

 

 

price

 

 

options

 

 

price

 

Balance, beginning of year

 

 

1,350,000

 

 

$

0.01

 

 

 

1,350,000

 

 

$

0.01

 

Granted

 

 

2,113,333

 

 

$

0.07

 

 

 

-

 

 

$

-

 

Balance, end of period

 

 

3,463,333

 

 

$

0.05

 

 

 

1,350,000

 

 

$

0.01

 

 

 

 

Range of

 

 

 

 

​

 

Weighted

 

 

Weighted

 

 

Exercisable on

 

 

 

Exercise

 

 

 

 

​

 

average

 

 

average

 

 

September 30,

 

 

 

prices

 

 

Outstanding

 

 

life (years)

 

 

exercise price

 

 

2026

 

Stock options

 

 

$0.01 - $0.07

 

 

 

3,463,333

 

 

 

8.15

 

 

$

0.05

 

 

 

1,350,000

 

 

25


Table of Contents

 

Note 16 - Segment Reporting 

 

The Company manages its business on a product basis and operates in the following two reporting segments for financial reporting purposes: (1) Hard Tonneau Covers and (2) Soft Tonneau Covers. The accounting policies of both reporting segments are the same as those described in Note 1, Description of Business and Summary of Significant Accounting Policies.

 

The Company’s chief operating decision maker (“CODM”) is the Chief Executive Officer, who regularly reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance of the Company’s reporting segments. The CODM primarily focuses on net income (loss) from continuing operations to evaluate its reporting segments. The CODM also uses net income (loss) from continuing operations for evaluating pricing strategy and assessing the performance for determining the compensation of certain employees. Significant segment expenses reviewed, which represent the differences between segment net sales and segment net loss from continuing operations, consist of the following:

 

 

 

For the three months ended September 30, 2026

 

 

For the three months ended September 30, 2025

 

 

 

Hard

 

 

Soft

 

 

 

 

​

 

 

 

​

 

Hard

 

 

Soft

 

 

 

 

​

 

 

 

​

 

 

Tonneau

 

 

Tonneau

 

 

Corporate /

 

 

 

 

​

 

Tonneau

 

 

Tonneau

 

 

Corporate /

 

 

 

 

​

 

 

Covers

 

 

Covers

 

 

Eliminations

 

 

Consolidated

 

 

Covers

 

 

Covers

 

 

Eliminations

 

 

Consolidated

 

Net sales

 

$

7,195,215

 

 

$

33,083

 

 

$

-

 

 

$

7,228,298

 

 

$

4,881,982

 

 

$

131,890

 

 

$

-

 

 

$

5,013,872

 

Cost of sales

 

 

(5,015,650

)

 

 

(23,941

)

 

 

-

 

 

 

(5,039,591

)

 

 

(3,341,071

)

 

 

(104,017

)

 

 

-

 

 

 

(3,445,088

)

Selling, general and administrative

 

 

(2,775,535

)

 

 

(16,561

)

 

 

(2,404,889

)

 

 

(5,196,985

)

 

 

(2,561,515

)

 

 

(30,700

)

 

 

(3,298,686

)

 

 

(5,890,901

)

Depreciation and amortization

 

 

(401,360

)

 

 

(3,335

)

 

 

(16,342

)

 

 

(421,037

)

 

 

(421,732

)

 

 

(7,866

)

 

 

(41,056

)

 

 

(470,654

)

Loss from continuing operations

 

$

(997,330

)

 

$

(10,754

)

 

$

(2,421,231

)

 

$

(3,429,315

)

 

$

(1,442,336

)

 

$

(10,693

)

 

$

(3,339,742

)

 

$

(4,792,771

)

 

 

 

For the nine months ended September 30, 2026

 

 

For the nine months ended September 30, 2025

 

 

 

Hard

 

 

Soft

 

 

 

 

​

 

 

 

​

 

Hard

 

 

Soft

 

 

 

 

​

 

 

 

​

 

 

Tonneau

 

 

Tonneau

 

 

Corporate /

 

 

 

 

​

 

Tonneau

 

 

Tonneau

 

 

Corporate /

 

 

 

 

​

 

 

Covers

 

 

Covers

 

 

Eliminations

 

 

Consolidated

 

 

Covers

 

 

Covers

 

 

Eliminations

 

 

Consolidated

 

Net sales

 

$

15,626,430

 

 

$

144,328

 

 

$

-

 

 

$

15,770,758

 

 

$

10,982,236

 

 

$

376,599

 

 

$

-

 

 

$

11,358,835

 

Cost of sales

 

 

(10,977,492

)

 

 

(100,677

)

 

 

-

 

 

 

(11,078,169

)

 

 

(8,014,766

)

 

 

(292,725

)

 

 

(4,227

)

 

 

(8,311,718

)

Selling, general and administrative

 

 

(7,952,247

)

 

 

(71,265

)

 

 

(8,394,335

)

 

 

(16,417,847

)

 

 

(7,087,353

)

 

 

(148,686

)

 

 

(7,135,117

)

 

 

(14,371,156

)

Depreciation and amortization

 

 

(1,158,717

)

 

 

(12,461

)

 

 

(95,609

)

 

 

(1,266,787

)

 

 

(1,268,853

)

 

 

(31,003

)

 

 

(59,666

)

 

 

(1,359,522

)

Loss from continuing operations

 

$

(4,462,026

)

 

$

(40,075

)

 

$

(8,489,944

)

 

$

(12,992,045

)

 

$

(5,388,736

)

 

$

(95,815

)

 

$

(7,199,010

)

 

$

(12,683,561

)

 

The following table presents the Company’s net sales disaggregated by geographic area:

 

 

 

2026

 

 

2025

 

 

 

Hard

 

 

Soft

 

 

 

 

​

 

Hard

 

 

Soft

 

 

 

 

​

 

 

Tonneau

 

 

Tonneau

 

 

 

 

​

 

Tonneau

 

 

Tonneau

 

 

 

 

​

 

 

Covers

 

 

Covers

 

 

Consolidated

 

 

Covers

 

 

Covers

 

 

Consolidated

 

United States

 

$

15,569,910

 

 

$

144,170

 

 

$

15,714,080

 

 

$

10,910,214

 

 

$

374,324

 

 

$

11,284,538

 

Canada

 

 

56,520

 

 

 

158

 

 

 

56,678

 

 

 

72,022

 

 

 

2,275

 

 

 

74,297

 

Total Net sales

 

$

15,626,430

 

 

$

144,328

 

 

$

15,770,758

 

 

$

10,982,236

 

 

$

376,599

 

 

$

11,358,835

 

 

No asset information has been provided for the reported segments as the CODM does not regularly review asset information by reportable segment. As of  September 30, 2026 and  December 31, 2025, assets held in the U.S. accounted for 94% and 93% of total assets for each period, respectively.

 

26


Table of Contents

 

Note 17 - Commitments and Contingencies

 

From time to time, the Company is involved in lawsuits, claims, investigations and proceedings arising in the ordinary course of business, including opposition proceedings involving patents. As of  September 30, 2026, the Company was not a party to any legal proceeding that management believed would have a material adverse effect on the Company’s business, financial condition or results of operations.

 

Note 18 - Subsequent Events

 

The Company has evaluated subsequent events through  November 10, 2026. The following events occurred after the nine months ended September 30, 2026:

 

 

●

On November 9, 2026, the Board of Directors of the Company, upon the recommendation of the Compensation Committee, by unanimous written consent, approved an option exchange program under the Company’s 2022 Equity Incentive Plan. See Part II, Item 5, “Other Information,” of this Quarterly Report on Form 10-Q for a description of the option exchange program. 

 

 

 

 

●

On November 9, 2026, the Board of Directors of the Company, upon the recommendation of the Compensation Committee, by unanimous written consent, approved grants under the 2022 Plan of non-qualified stock options to purchase 2,200,000 shares to Steven Rossi, Chairman and Chief Executive Officer, and 50,000 shares each to directors Lorenzo Rossi, Ned Siegel, Craig Loverock and William Caragol, with the same grant date, exercise price, vesting terms and ten-year term as the new options described above. Each grant will be satisfied first from the shares under the 2022 Plan on the grant date, after reserving the maximum number of new options issuable in exchange for options granted under the 2015 and 2021 Equity Incentive Plans. To the extent a grant exceeds those available shares, the excess may not be exercised unless and until either the Company's shareholders approve an increase in the 2022 Plan share reserve or sufficient shares become available under the 2022 Plan, including through the automatic quarterly increases under its evergreen provision. If sufficient shares have not become available by the date of the Company's 2027 Annual Meeting of Shareholders, the Company will submit a proposal to increase the 2022 Plan share reserve at that meeting, and any portion of the grant that then exceeds the available shares will be forfeited if the shareholders do not approve it. Each recipient abstained from the approval of his own grant.

 

 

 

 

●

On November 9, 2026, the Board of Directors of the Company, upon the recommendation of the Compensation Committee, by unanimous written consent, approved (i) Amendment No.1 to the Consulting Agreement, dated as of July 23, 2024, among the Company, 2230164 Ontario Inc. and Steven Rossi, which provides for a transaction bonus equal to 10% of the consideration received by the Company upon the sale of a subsidiary payable in cash or in kind, subject to a Section 280G cutback and a change-in-control non-competition agreement, and (ii) a transaction bonus and carve-out plan establishing a bonus pool of 4% of the consideration received by the Company in a qualified strategic transaction involving its Worksport or Terravis Energy businesses, with participants including Jennifer Kartychak, Chief Financial Officer (whose award equals 1.00% of the transaction consideration), other members of senior management, and independent directors William Caragol, Craig Loverock, and Ned Siegel. Each award under the plan is subject to a Section 280G cutback and conditioned on the participant's execution of a change-in-control non-competition agreement.

 

The Company is evaluating the incremental compensation cost associated with the modification of the disclosed option exchange program under ASC 718.

 

27


Table of Contents

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

This section and other parts of this Quarterly Report on Form 10-Q (“Form 10-Q”) contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, that involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Forward-looking statements can also be identified by words such as “future,” “anticipates,” “believes,” “estimates,” “expects,” “intends,” “plans,” “predicts,” “will,” “would,” “could,” “can,” “may,” and similar terms. Forward-looking statements are not guarantees of future performance and actual results may differ significantly from the results discussed in the forward-looking statements. All forward-looking statements in this Form 10-Q are made based on current expectations, forecasts, estimates and assumptions, and involve risks, uncertainties and other factors that could cause results or events to differ materially from those expressed in the forward-looking statements. In evaluating these statements, various factors, uncertainties, and risks should be specifically considered that could affect future results or operations. These factors, uncertainties and risks may cause actual results to differ materially from any forward-looking statement set forth in this Form 10-Q. These risks and uncertainties described and other information contained in the reports filed with or furnished to the SEC should be carefully considered before making any investment decision with respect to the Company’s securities. The Company assumes no obligation to revise or update any forward-looking statements for any reason, except as required by law.

 

Unless otherwise stated, all information presented herein is based on the Company’s fiscal calendar, and references to particular years, quarters, months or periods refer to the Company’s fiscal years ended December 31st and the associated quarters, months and periods of those fiscal years. Each of the terms “Company” and “Worksport” as used herein refers collectively to Worksport Ltd. and its subsidiaries, unless otherwise stated.

 

The following discussion should be read in conjunction with the Company’s Annual Report Form 10-K for the fiscal year ended December 31, 2025 filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 26, 2026 and the condensed consolidated financial statements and accompanying notes included in Part I, Item 1 of this Form 10-Q.

 

OVERVIEW

 

Worksport Ltd., through its subsidiaries, designs, develops, manufactures and sells tonneau covers, portable energy storage systems, and solar-integrated automotive accessories, and is developing other energy technologies, including pre-commercial non-parasitic heat-pump technology. The Company owns intellectual property associated with these products and technologies. We seek to expand our automotive-accessory business while commercializing selected clean-energy products and technologies, subject to product-development, regulatory, manufacturing, market-acceptance and financing risks.

 

Rising Popularity of Electric Vehicles

 

Electric Vehicles (EVs) have been increasing in consumer interest, whether that interest takes the form of vehicle pre-orders, sales, or investments. As we begin marketing our Worksport SOLIS and COR, we plan to market the SOLIS to electric light duty vehicle owners and to leverage consumer interest in EVs to promote our other products (COR and conventional tonneau covers) to the very large population of Americans who have an interest in EVs without the funds to purchase them. Further, participating in the EV space allows us to target consumers with an interest in cutting-edge technologies – a market in which to promote our COR portable power system.

 

28


Table of Contents

 

Regulatory Environment Favoring Electric Vehicles

 

Many regulations that improve North America’s EV charging infrastructure or provide grants to businesses operating in the EV space would benefit us. While we are primarily focused on the light duty vehicle market, our energy products are particularly useful for electric light duty pickup trucks and, therefore, could benefit from any bill that increases the prevalence of such vehicles. However, President Donald Trump has signed an executive order titled Unleashing American Energy in which he has indicated his administration will be reversing the electric vehicle mandates of Joe Biden’s former administration, and he has further paused billions of dollars in funding allocated towards electric vehicle charging stations. The future of the U.S.’s regulatory environment surrounding electric vehicles is uncertain.

 

Limited Competitive Landscape

 

Our conventional tonneau covers are engineered for enhanced user experience and resistance to wear-and-tear, in a consolidated and competitive market. The Worksport COR portable power station, however, operates in a much wider yet unsaturated market. The global Portable Power Station market is quickly growing, and the competitive landscape is far from consolidated. The solar tonneau cover market is in its infancy, and we believe we are among the early entrants in this market. To ensure we do not fall behind future competitors, we are highly focused on protecting our intellectual property both domestically and abroad.

 

Economic Conditions and Market Trends

 

As a result of a number of factors, our historical results of operations may not be comparable to our results of operations in future periods, and our results of operations may not be directly comparable from period to period. Set forth below is a brief discussion of the key factors impacting our results of operations.

 

Tariffs and Supply Chain Impact

 

Our hybrid manufacturing model, which includes sourcing certain products and components from overseas—particularly from China—exposes us to risks associated with tariffs and evolving global trade policies. Tariffs on imported raw materials, components, and finished goods have increased our input costs and may continue to do so in the future. During fiscal 2025, increases in certain material and component costs attributable, in part, to tariffs contributed to higher cost of goods sold; however, these increases were offset by higher production volumes, improved overhead absorption, and operational efficiencies, resulting in an overall improvement in gross margins compared to the prior fiscal year. These impacts are both direct, through duties applied to imported products and components, and indirect, as suppliers and logistics providers may pass through increased costs associated with tariff regimes and related trade restrictions.

 

While we have taken steps to mitigate these risks through supplier diversification, a portion of our supply chain remains dependent on foreign sources. As a result, tariffs and other trade measures may continue to increase our cost of goods sold and may impact product pricing and margins to the extent not offset by operational efficiencies or pricing actions. In addition, changes in U.S. trade policy or further escalation of tariffs could disrupt supply availability or increase lead times, which may adversely affect our operations and results of operations.

 

Geopolitical and Macroeconomic Conditions


Recent geopolitical developments, including conflicts in the Middle East involving Iran, have contributed to volatility in global financial markets, higher energy prices and inflationary pressures. While we do not have direct exposure to the affected regions through our suppliers, customers, or operations, these conditions may adversely affect our business. In particular, increases in global energy and transportation costs may increase our cost of goods sold, and inflationary pressures may increase the cost of materials sourced from our suppliers, including suppliers in Asia. In addition, such conditions may adversely affect consumer discretionary spending, which could reduce demand for our products. Volatility in the capital markets may also affect our ability to raise capital on favorable terms. The extent and duration of these conditions remain uncertain and could adversely affect our business, financial condition and results of operations.

 

29


Table of Contents

 

Climate Change

 

Climate change threatens to cause many foreseeable as well as unforeseeable ramifications. In cautious preparation for those that are foreseeable, we have strategically begun domestic manufacturing operations in Western New York. Further, we intend to lower our own carbon footprint by investing in energy-saving measures in our factory in West Seneca, NY. Considering climate change may also exacerbate geopolitical tensions, we are working to diversify our supply chain and lower our reliance on any particular region or country for raw materials in order to lower our exposure to climate change-induced economic or political instability.

 

We acknowledge the potentially negative environmental impacts of poor battery recycling and increasing demand for precious metals. We are actively researching ways to lower such environmental impacts.

 

Inflation

 

Prices of certain commodity products, including raw materials, are historically volatile and are subject to fluctuations arising from changes in domestic and international supply and demand, labor costs, competition, market speculation, government regulations, trade restrictions and tariffs. Increasing prices of the component materials for parts of our goods may impact the availability, quality and price of our products as suppliers search for alternatives to existing materials and increase the prices they charge. Our suppliers may also fail to provide consistent quality of product as they may substitute lower cost materials to maintain pricing levels. Rapid and significant changes in commodity prices may negatively affect our profit margins, and it may be difficult to mitigate worsened margins through customer pricing actions and cost reduction initiatives.

 

Additionally, as central banks and the U.S. Federal Reserve adjust interest rates in response to evolving inflationary conditions, the cost of debt financing may fluctuate. While the Federal Reserve began reducing the federal funds rate in the latter half of 2024 and has continued reductions since, interest rates remain elevated relative to pre-2022 levels, and the pace and extent of future reductions remain uncertain. Our $6,000,000 revolving line of credit and our $1,487,000 in equipment financing both carry floating interest rates, meaning we remain susceptible to variable debt interest costs as a result of changes in interest rates.

 

High interest rates have also resulted in a shift in institutional holdings away from micro-cap equities, which has negatively influenced our stock’s trading volume. We continue to forge relationships with institutional investors and analysts in order to maintain a healthy trading volume.

 

Gasoline Prices and Supply Chain Issues

 

We faced significantly higher ocean freight, trucking, and container handling costs as well as last mile delivery costs in recent years – all of which have increased our products’ landed costs. Higher oil and gasoline prices further increased these costs, and while such prices have come down from their 2022 highs, we continue to closely monitor gasoline and shipping costs. While the Freight Rate Index has significantly increased during certain periods due to geopolitical tensions and disruptions affecting global shipping routes, the shipping routes used by Worksport have not faced dramatic price hikes. Regardless, Worksport is closely monitoring international shipping costs.

 

Our transition towards domestic manufacturing and assembly is anticipated to largely offset these higher costs, as we believe we will be less exposed to higher international shipping costs. We are also identifying North American suppliers of our products’ components and will prioritize transport by rail when possible to avoid high trucking costs.

 

30


Table of Contents

 

Foreign Currencies
 

We are subject to foreign exchange risk as we manufacture certain products and components in China, market extensively in both Canadian and U.S. markets, employ people residing in both the U.S. and Canada and, to date, have raised funds in Canadian Dollars. Meanwhile, we report results of operations in U.S. Dollars. Since our Canadian customers pay in Canadian Dollars, we are subject to gains and losses due to fluctuations in the USD relative to the Canadian Dollar. Our manufacturers in China are paid in USD to better avoid the relatively greater fluctuation of the Chinese Yuan. To the extent the U.S. dollar strengthens against any of these foreign currencies, the translation of these foreign currencies denominated transactions results in reduced revenue, operating expenses and net income for our operations.

 

Business Developments

 

The following highlights recent material developments in our business in the three months ended September 30, 2026:

 

 

●

As previously disclosed in the Company's Current Report on Form 8-K filed with the SEC on August 14, 2026, on August 13, 2026, the Company received written notice from Nasdaq that it no longer satisfies the $1.00 minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The Company has until February 9, 2027 to regain compliance, which requires a closing bid price of at least $1.00 per share for at least 10 consecutive business days. If the Company does not regain compliance by that date, it may be eligible for an additional 180-calendar-day compliance period if it meets the applicable conditions, including providing written notice of its intention to cure the deficiency, by effecting a reverse stock split if necessary.

 

 

 

 

●

As previously disclosed in the Company's Current Report on Form 8-K filed with the SEC on August 27, 2026, on August 27, 2026, the Company entered into a warrant exercise inducement letter with the holder of warrants effective on December 12, 2025 to purchase 3,840,421 shares of common stock. The holder exercised those warrants for cash at a reduced exercise price of $0.60 per share and the Company issued the holder new warrants to purchase up to 4,800,526 shares of common stock at an exercise price of $0.60 per share. The transaction closed on August 28, 2026, and the Company received gross proceeds of approximately $2,304,253, before deducting fees and expenses.

 

 

 

 

●

As previously disclosed in the Company's Current Report on Form 8-K filed with the SEC on September 4, 2026,  at the Annual Meeting of Shareholders held on September 3, 2026, the shareholders elected five directors, ratified the appointment of Lumsden & McCormick, LLP as the Company's independent registered public accounting firm for 2026, approved an advisory proposal supporting the Board's consideration of special dividends in connection with the sale of any business unit or material asset, and authorized the Board to effect one or more reverse stock splits at an aggregate ratio of not less than 1-for-2 and not greater than 1-for-250, or one or more forward stock splits, at any time before September 3, 2028.

 

31


Table of Contents

 

Recent Developments

 

The following material developments occurred after September 30, 2026:

 

 

●

On October 5, 2026, the Company filed a registration statement on Form S-3 (File No. 333-299283) to register the resale of the 4,800,526 shares of common stock issuable upon exercise of the warrants issued in the August 2026 warrant inducement transaction. The SEC declared the registration statement effective on October 13, 2026.

 

 

 

 

●

On October 9, 2026, the Company filed a registration statement on Form S-8 to register an additional 1,452,276 shares of common stock issuable under the Company's 2022 Equity Incentive Plan.

 

 

 

 

●

As previously announced in a press release furnished as an exhibit to the Company's Current Report on Form 8-K furnished to the SEC on November 4, 2026, the Company signed a non-binding term sheet to acquire a U.S. business that manufactures a patented truck bed accessory. Completion of the proposed acquisition is subject to due diligence, the negotiation and execution of definitive agreements, and the satisfaction of closing conditions. There can be no assurance that a definitive agreement will be signed or that the proposed acquisition will be completed.

 

 

 

 

●

On November 9, 2026, the Board of Directors of the Company, upon the recommendation of the Compensation Committee, approved an option exchange program, grants of stock options to the Company's Chief Executive Officer and non-employee directors, and certain transaction bonus arrangements. See Part II, Item 5, “Other Information” of this Quarterly Report on Form 10-Q.

 

CRITICAL ACCOUNTING ESTIMATES

 

There have been no material changes to our critical accounting estimates from those disclosed under “Management's Discussion and Analysis of Financial Condition and Results of Operations - Critical Accounting Estimates” in our Annual Report on Form 10-K for the year ended December 31, 2025.

 

RECENT ACCOUNTING PRONOUNCEMENTS

 

See Note 1, Description of Business and Significant Accounting Policies included in Item 1, Financial Statements of this report for further information regarding Financial Accounting Standards Board issued Accounting Standards Updates (“ASU”).

 

32


Table of Contents

 

CONSOLIDATED RESULTS OF OPERATIONS

 

The following is a discussion of our results of operations for the three months ended September 30, 2026 compared to the three months ended September 30, 2025

 

 

 

 

 

​

 

 

 

​

 

Increase (Decrease)

 

 

 

Three months ended September 30,

 

 

2026 vs. 2025

 

 

 

2026

 

 

2025

 

 

Amount

 

 

%

 

Net sales

 

$

7,228,298

 

 

$

5,013,872

 

 

$

2,214,426

 

 

 

44.2

%

Cost of sales

 

 

5,039,591

 

 

 

3,445,088

 

 

 

1,594,503

 

 

 

46.3

%

Gross profit

 

 

2,188,707

 

 

 

1,568,784

 

 

 

619,923

 

 

 

39.5

%

Research and development

 

 

212,914

 

 

 

301,095

 

 

 

(88,181

)

 

 

(29.3

)%

General and administrative

 

 

3,581,905

 

 

 

3,698,756

 

 

 

(116,851

)

 

 

(3.2

)%

Sales and marketing

 

 

1,817,563

 

 

 

2,362,195

 

 

 

(544,632

)

 

 

(23.1

)%

(Gain) loss on foreign exchange

 

 

5,640

 

 

 

(491

)

 

 

6,131

 

 

 

1248.7

%

Loss from operations

 

 

(3,429,315

)

 

 

(4,792,771

)

 

 

1,363,456

 

 

 

(28.4

)%

Interest expense

 

 

(175,243

)

 

 

(138,887

)

 

 

(36,356

)

 

 

26.2

%

Other

 

 

5,166

 

 

 

2,979

 

 

 

2,187

 

 

 

73.4

%

Net loss

 

$

(3,599,392

)

 

$

(4,928,679

)

 

$

1,329,287

 

 

 

(27.0

)%

Per share data

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Basic and diluted earnings per share

 

$

(0.26

)

 

$

(0.75

)

 

$

0.49

 

 

 

64.9

%

 

 

 

Three months ended September 30,

 

 

Increase (Decrease)

 

Percent of net sales

 

2026

 

 

2025

 

 

Percentage points

 

Cost of sales

 

 

70

%

 

 

69

%

 

 

1.0

%

Gross profit

 

 

30

%

 

 

31

%

 

 

(1.0

)%

Research and development expense

 

 

3

%

 

 

6

%

 

 

(3.1

)%

General and administrative expense

 

 

50

%

 

 

74

%

 

 

(24.2

)%

Sales and marketing expense

 

 

25

%

 

 

47

%

 

 

(22.0

)%

 

33


Table of Contents

 

Net sales

 

For the three months ended September 30, 2026, net sales generated in the U.S. were $7,209,675, compared to $4,986,583 for the same period in 2025, an increase of approximately $2,223,092.

 

The increase was primarily due to increased sales of tonneau covers to end users via various dealers and distributors. The Company increased its product offerings in 2026 to also include NEXUS covers to end customers. The Company continues to focus on establishing, as well as strengthening, its presence in both the direct-to-consumer and business-to-business sales channels while also strengthening customer support to increase customer satisfaction.

 

We distribute our products in the U.S. and Canada through an expanding network of wholesalers, distributors, and dealers, and through online channels, including major online marketplaces and our direct-to-consumer e-commerce platform. We intend to continue expanding both business-to-business and direct-to-consumer channels with product offerings to each of these channels. We also continue to pursue relationships with original equipment manufacturers and fleet customers where appropriate.

 

Net sales from online retailers of our products increased by $575,032, from $3,589,098 for the three months ended September 30, 2025 to $4,164,130 for the three months ended September 30, 2026. The $575,032 increase is a result of the Company’s focus on lowering customer acquisition costs with direct-to-consumer sales by expanding its sales channel concentration in the business-to-business sale channel. This, in turn, allows the Company to reduce expenses normally attributed to conversion marketing. An intentional reduction in conversion marketing efforts decreases order volume, but yields efficient marketing spend and therefore an increase in average order value.

 

Cost of Sales
 

The increase in the cost of sales as a percentage of net sales was primarily offset by two efficiency factors: (1) increased production volume to support sales growth, including introduction of new product lines during 2026, and (2) overhead allocation efficiencies associated with higher production volume. These improvements partially offset increases in certain material, components, and landed costs, including the impact of tariffs on imported products and components sourced from overseas. While tariffs contributed to higher input costs during the three months ended September 30, 2026, the efficiency improvements partially offset the increase in input costs, and gross margin decreased by approximately one percentage point.

 

34


Table of Contents

 

We continue to employ a discounting strategy as part of a broader initiative to enhance market presence and build brand awareness. We anticipate this will position us well for sustained customer engagement in future periods, during which discounting may not be necessary to the same extent. As production volume grows and our manufacturing process becomes more efficient, we expect to allocate fixed costs included in overhead absorption against a larger production volume base. This scaling will be facilitated by reallocating more of our existing human capital and machinery resources toward production. 

 

We provide our distributors and online retailers with an “all-in” wholesale price. This includes any import duty charges, taxes, and shipping charges. Discounts are applied if the distributor or retailer chooses to use their own shipping process. Certain exceptions apply on rare occasions where product is shipped outside the contiguous United States or from the U.S. to Canada. Volume discounts are offered to certain high-volume customers, and we also offer a “dock price” or “pickup program” whereby clients are able to pick up product directly from our stocking warehouse.

 

Operating Expenses

 

Operating expense for the three months ended September 30, 2026 decreased by $743,533, from $6,361,555 for the three months ended September 30, 2025 to $5,618,022, for the three months ended September 30, 2026 mainly due to the following factors:

 

 

●

Research and development expense decreased by $88,181, from $301,095 for the three months ended September 30, 2025 to $212,914 for the three months ended September 30, 2026. The decrease was related to developmental progress of our AL4 and NEXUS product lines, which required less research and development effort as resources were shifted to normal-course production.

 

 

 

 

●

General and administrative expense decreased by $116,851, from $3,698,756 in 2025 to $3,581,905 in 2026. The decrease was primarily related to a maintained focus on operational efficiencies as the Company continues to add sales volume.

 

 

 

 

●

Sales and marketing expense decreased by $544,632, from $2,362,195 in 2025 to $1,817,563 in 2026. The decrease in sales and marketing was primarily attributable to a reduction of approximately $1.0M in investor relations and awareness program costs, partially offset by an increase in customer facing marketing to support higher sales volume. Customer-facing marketing supported a 44% increase in net sales.

 

Other Income and Expenses

 

We reported net other expenses for the three months ended September 30, 2026 of $170,077, compared to $135,908 for the three months ended September 30, 2025. The increase in net other expenses was attributed to a greater use of our line of credit to fund working capital requirements, which contributed to an increase in interest expense.

 

Net Loss

 

Net loss for the three months ended September 30, 2026 was $3,599,392, compared to a net loss of $4,928,679 for the three months ended September 30, 2025 – a decrease of approximately 27.0%. The decrease in net loss can be attributed to the reduction in various operating expenses as we focus on maximizing cost efficiencies as we continue to scale.

 

35


Table of Contents

 

The following is a discussion of our results of operations for the nine months ended September 30, 2026 compared to the nine months ended September 30, 2025 
 

 

 

 

 

 

​

 

 

 

​

 

Increase (Decrease)

 

 

 

Nine months ended September 30,

 

 

2026 vs. 2025

 

 

 

2026

 

 

2025

 

 

Amount

 

 

%

 

Net sales

 

$

15,770,758

 

 

$

11,358,835

 

 

$

4,411,923

 

 

 

38.8

%

Cost of sales

 

 

11,078,169

 

 

 

8,311,718

 

 

 

2,766,451

 

 

 

33.3

%

Gross profit

 

 

4,692,589

 

 

 

3,047,117

 

 

 

1,645,472

 

 

 

54.0

%

Research and development

 

 

632,429

 

 

 

975,529

 

 

 

(343,100

)

 

 

(35.2

)%

General and administrative

 

 

11,369,927

 

 

 

10,221,979

 

 

 

1,147,948

 

 

 

11.2

%

Sales and marketing

 

 

5,680,624

 

 

 

4,537,299

 

 

 

1,143,325

 

 

 

25.2

%

(Gain) loss on foreign exchange

 

 

1,654

 

 

 

(4,129

)

 

 

5,783

 

 

 

140.1

%

Loss from operations

 

 

(12,992,045

)

 

 

(12,683,561

)

 

 

(308,484

)

 

 

2.4

%

Interest expense

 

 

(414,462

)

 

 

(462,481

)

 

 

48,019

 

 

 

(10.4

)%

Other

 

 

13,290

 

 

 

22,415

 

 

 

(9,125

)

 

 

(40.7

)%

Net loss

 

$

(13,393,217

)

 

$

(13,123,627

)

 

$

(269,590

)

 

 

2.1

%

Per share data

 

 

 

​

 

 

 

​

 

 

 

​

 

 

 

​

Basic and diluted earnings per share

 

$

(1.12

)

 

$

(2.44

)

 

$

1.32

 

 

 

54.1

%

 

 

 

Nine months ended September 30,

 

 

Increase (Decrease)

 

Percent of net sales

 

2026

 

 

2025

 

 

Percentage points

 

Cost of sales

 

 

70

%

 

 

73

%

 

 

(2.9

)%

Gross profit

 

 

30

%

 

 

27

%

 

 

2.9

%

Research and development expense

 

 

4

%

 

 

9

%

 

 

(4.6

)%

General and administrative expense

 

 

72

%

 

 

90

%

 

 

(17.9

)%

Sales and marketing expense

 

 

36

%

 

 

40

%

 

 

(3.9

)%

 

36


Table of Contents

 

Net sales

 

For the nine months ended September 30, 2026, net sales generated in the U.S. was $15,714,080, compared to $11,284,538 for the same period in 2025, an increase of approximately 39.3%.
 

Net sales increased during the nine months ended September 30, 2026 compared to the same period in the prior year due to increased sales of hard tonneau covers to end users via various dealers and distributors. The Company increased its product offerings in 2025 to also include AL4 and HD3 covers to end customers. In 2026, the Company added the NEXUS product offering to its customers. The Company continues to focus on establishing, as well as strengthening, its presence in both the direct-to-consumer and business-to-business sales channels while also strengthening customer support to increase customer satisfaction and increase product turnover.

 

We distribute our products in the U.S. and Canada through an expanding network of wholesalers, distributors, and dealers, and through online channels, including major online marketplaces and our direct-to-consumer e-commerce platform. We intend to continue expanding both business-to-business and direct-to-consumer channels with product offerings unique to each of these channels. We also continue to pursue relationships with original equipment manufacturers and fleet customers where appropriate.

 

Net sales from online retailers of our products increased by $273,293, from $8,581,631 for the nine months ended September 30, 2025 to $8,854,924 for the nine months ended September 30, 2026. The 3.2% increase is a result of the Company’s focus on lowering customer acquisition costs for direct-to-consumer sales and a presence in the business-to-business sales channel. This, in turn, allows the Company to reduce expenses normally attributed to conversion marketing. An intentional reduction in conversion marketing efforts decreases order volume, but results in more efficient marketing spend and a higher average order value.

 

Cost of Sales

 

The decrease in the cost of sales as a percentage of net sales was primarily driven by two factors: (1) increased production volume to support sales growth, including introduction of new product lines during 2025 and 2026, including NEXUS, and (2) overhead allocation efficiencies associated with higher production volume. These improvements offset increases in certain material, components, and landed costs, including the impact of tariffs on imported products and components sourced from overseas. While tariffs contributed to higher input costs during the nine months ended September 30, 2026, the overall effect of increased scale and production efficiencies resulted in an improvement in our gross margin.

 

We continue to employ a discounting strategy as part of a broader initiative to enhance market presence and build brand awareness. We anticipate this will position us well for sustained customer engagement in future periods, during which discounting may not be necessary to the same extent. As production volume grows and our manufacturing process becomes more efficient, we expect to allocate fixed costs included in overhead absorption against a larger production volume base. This scaling will be facilitated by reallocating more of our existing human capital and machinery resources toward production. 

 

We provide our distributors and online retailers with an “all-in” wholesale price. This includes any import duty charges, taxes, and shipping charges. Discounts are applied if the distributor or retailer chooses to use their own shipping process. Certain exceptions apply on rare occasions where product is shipped outside the contiguous United Sates or from the U.S. to Canada. Volume discounts are offered to certain high-volume customers, and we also offer a “dock price” or “pickup program” whereby clients are able to pick up product directly from our stocking warehouse.

 

37


Table of Contents

 

Operating Expenses

 

Operating expenses increased for the nine months ended September 30, 2026 by $1,953,956, from $15,730,678 for the nine months ended September 30, 2025 to $17,684,634 for the nine months ended September 30, 2026, mainly due to the following factors:

 

 

●

Research and development expense decreased by $343,100, from $975,529 for the nine months ended September 30, 2025 to $632,429 for the nine months ended September 30, 2026. The decrease was related to developmental progress of our AL4 and NEXUS product lines, which required less research and development effort as resources were shifted to normal-course production.

 

 

 

 

●

General and administrative expense increased by $1,147,948, from $10,221,979 in 2025 to $11,369,927 in 2026. The increase was related to consulting costs to support production and operational efforts.

 

 

 

 

●

Sales and marketing expense increased by $1,143,325, from $4,537,299 in 2025 to $5,680,624 in 2026. The increase in sales and marketing was primarily attributable to marketing campaigns to promote brand awareness and new product lines.

 

Other Income and Expenses

 

We reported net other expenses for the nine months ended September 30, 2026 of $401,172, compared to $440,066 for the nine months ended September 30, 2025. The decrease in net other expenses was attributed to decreased interest expense on our line of credit as a result of reduced usage following cash inflows as a result of the December 2025 warrant inducement transaction.

 

Net Loss

 

Net loss for the nine months ended September 30, 2026 was $13,393,217, compared to a net loss of $13,123,627 for the nine months ended September 30, 2025 – an increase of approximately 2.1%. The increase in net loss can be attributed to the increase in various operating expenses as we focus on expanding our operations and promoting our brand awareness.

 

38


Table of Contents

 

Liquidity and Capital Resources

 

As of September 30, 2026 and December 31, 2025, we had $2,528,222 and $5,945,894, respectively in cash and cash equivalents. As of September 30, 2026, we had $1,818,887 of remaining available capacity on our revolving line of credit compared with $3,448,016 of remaining available capacity as of December 31, 2025. The decrease in cash and cash equivalents was primarily a result of our cash used in operating activities to fund working capital requirements and support the production of our new product offerings. We have historically generated limited gross profit and have relied primarily upon capital generated from public and private offerings of our securities to fund continuing operations. Since the Company’s acquisition of Worksport in 2014, it has never generated a profit. During the three and nine months ended September 30, 2026, we had net losses of $3,599,392 and $13,393,217, respectively (three months ended September 30, 2025 - $4,928,679; nine months ended September 30, 2025 - $13,123,627). As of September 30, 2026, the Company had working capital of $9,408,182 (As of December 31, 2025 - $10,061,578) and had an accumulated deficit of $97,348,858 (As of December 31, 2025 - $83,873,790).

 

In their fiscal 2025 audit report, our independent registered public accounting firm included an explanatory paragraph stating that there is substantial doubt about our ability to continue as a going concern. Our ability to continue as a going concern is dependent upon our ability to generate cash flows from operations and obtain equity and/or debt financing. We intend to continue funding operations through equity and debt financing arrangements, which may be insufficient to fund our capital expenditures, working capital and other cash requirements in the long term. There can be no assurance that the steps our management is taking will be successful.

 

To date, our principal sources of liquidity consist of net proceeds from public and private securities offerings and cash exercises of outstanding warrants. During the nine months ended September 30, 2026, the Company received net proceeds of $7,100,326 from the offerings described below. Management is focused on transitioning towards gross profit as our principal source of liquidity by growing our existing product offerings and customer base and realizing manufacturing efficiency improvements. We cannot give assurance that we can increase our cash balances or limit our cash consumption and thus maintain sufficient cash balances for our planned operations or future business developments. Future business development and demands may lead to cash utilization at levels greater than recently experienced. We may need to raise additional capital in the future. However, we cannot ensure that we will be able to raise additional capital on acceptable terms, or at all.

 

We have raised funds during the nine months ended September 30, 2026 from the following public and private securities offerings:

 

ATM Shares

 

On November 14, 2025, the Company entered into an amendment to its At The Market Offering Agreement, dated September 30, 2022, with H.C. Wainwright & Co., LLC (“Wainwright”) in connection with a new shelf registration statement on Form S-3 (File No. 333-291582), which was declared effective by the SEC on December 12, 2025. Pursuant to the amended ATM Agreement and the related prospectus supplement dated December 12, 2025, the Company may offer and sell shares of its common stock having an aggregate offering price of up to $4.0 million through Wainwright as sales agent. During the nine months ended September 30, 2026, the Company sold 4,006,728 shares of common stock under the ATM Agreement for aggregate gross proceeds of approximately $4,496,875, resulting in net proceeds of approximately $4,357,740 after deducting commissions and offering expenses.

 

Because the Company’s public float is below $75.0 million, sales under the ATM Agreement are subject to the limitations of General Instruction I.B.6 of Form S-3, which limits the amount of securities the Company may sell in primary offerings during any rolling 12-month period. As a result, the amount currently available for sale under the ATM Agreement may be significantly less than the aggregate amount registered under the Company’s shelf registration statement.

 

39


Table of Contents

 

Regulation A Offering

 

During the nine months ended September 30, 2026, we received $54,107 of proceeds net of issuance costs that had previously been held in escrow. The funds in escrow pertained to the 2025 Regulation A offering.

 

Registered Direct Offerings 
 

During the nine months ended September 30, 2026, we completed two registered direct offerings with one institutional accredited investor and received gross proceeds of $722,870, resulting in net proceeds of approximately $599,226 after deducting issuance costs.

 

August 2026 Warrant Inducement

 

On August 27, 2026, the Company entered into a warrant exercise inducement agreement with the holder of certain existing warrants originally issued on December 12, 2025. Pursuant to the agreement, the holder exercised warrants to purchase 3,840,421 shares of the Company’s common stock at a reduced exercise price of $0.60 per share, for gross proceeds of $2,304,253, before deducting approximately $215,000 of placement agent fees and other offering expenses payable, resulting in estimated net proceeds of approximately $2,089,253. In consideration for the exercise, the Company issued new warrants to purchase up to 4,800,526 shares of common stock. The shares of common stock issuable upon exercise of the new warrants were registered for resale pursuant to the Company’s registration statement on Form S-3 (File No. 333-299283), filed October 5, 2026, and declared effective October 13, 2026. The Company intends to use the net proceeds from the transaction for general corporate and working capital purposes. The Company engaged Maxim Group LLC as its exclusive financial advisor in connection with the transaction.

 

Consolidated Statement of Cash Flows

 

Cash and cash equivalents decreased from $5,945,894 at December 31, 2025, to $2,528,222 at September 30, 2026 – a decrease of $3,417,672 or 57.5%. The decrease was primarily due to the use of cash to fund working capital to support the production of existing product offerings and the expected growth of additional product offerings launched in 2026. The Company procured approximately $9.5 million of raw materials to support production of our expanded product lineup, including the SOLIS, COR and NEXUS product lines. Some of our new product offerings utilize raw materials common to existing product offerings. Approximately $0.6 million of these raw materials purchases remained in accounts payable as of September 30, 2026.

 

40


Table of Contents

 

Operating Activities

 

Net cash used in operating activities for the nine months ended September 30, 2026 was $12,043,036, compared to $11,190,182 in 2025, primarily driven by the launch of additional product offerings during the nine months ended September 30, 2026. Net cash used in operating activities did not exceed the Company’s net loss by approximately $1.3 million. The principal component of the change is attributable non-cash expenses, mainly equity compensation of $2,241,010 and depreciation and amortization expense of $1,266,787, which reduce reported earnings but did not require the use of cash during the period.

 

Accounts receivable increased at September 30, 2026 by $648,993 and increased by $472,485 in the prior year period. The increase in accounts receivable is based on the volume of shipment with various business-to-business customers as well as the concentration of customers in certain sales channels.

 

Inventory increased at September 30, 2026 by $52,868, and increased at September 30, 2025 by $1,645,437, as a result of the procurement of raw materials and production of finished goods to support the commercial launches of our COR, SOLIS and NEXUS product lines.

 

Prepaid expenses and other decreased by $68,344 at September 30, 2026, and increased by $865,634 at September 30, 2025 due to timing of advanced payments for professional services to support operations.

 

Accounts payable and accrued liabilities decreased at September 30, 2026 by $1,467,392 and increased by $1,477,537 at September 30, 2025 due to the timing of payment for raw materials and finished goods procured and produced in preparation for and support of the commercial launches of our COR, SOLIS and NEXUS product lines.

 

41


Table of Contents

 

Investing Activities

 

Net cash used in investing activities for the nine months ended September 30, 2026 was $274,877 compared to $1,067,257 for the nine months ended September 30, 2025. The decrease in investing activities was primarily attributable to the timing of machinery and equipment to support our production growth.

 

Financing Activities

 

Net cash provided by financing activities for the nine months ended September 30, 2026 was $8,900,241 compared to net cash provided by financing activities of $11,136,030 for the nine months ended September 30, 2025. Net cash provided by financing activities was principally attributable to our use of the ATM, whereby we received net proceeds of $4,357,740. We also received proceeds from our line of credit through net borrowings of $1,852,369 for the nine months ended September 30, 2026. In June 2026, we completed two registered direct offerings with one institutional accredited investor for gross proceeds of $722,870, resulting in net proceeds of approximately $599,226 after deducting issuance costs. In August 2026, we completed a warrant inducement and received gross proceeds of $2,304,253.

 

Material Contractual Obligations

 

On June 30, 2026, the Company amended an agreement pursuant to which it was released from an outstanding contractual obligation of approximately $2.7 million related to the acquisition of manufacturing equipment from Prima Power, representing approximately 90% of the total equipment cost of approximately $3.0 million. The amendment provides for Prima Power to retain the initial 10% equipment deposit of $300,000 to be applied to a future equipment purchase. The equipment deposit of $300,000 is included in other noncurrent assets as of September 30, 2026. Other than the indebtedness, leases, purchases, employment and other obligations disclosed in this Form 10-Q or incurred in the ordinary course of business, the Company had no material contractual obligations as of September 30, 2026.

 

Off-Balance Sheet Arrangements

 

We did not have any material off-balance sheet arrangements that have or are reasonably likely to have a material future effect on our financial condition, results of operations or cash flows.

 

42


Table of Contents

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

As a “smaller reporting company,” as defined by Rule 12b-2 of the Exchange Act, we are not required to provide the information in this Item.

 

Item 4. Controls and Procedures

 

Disclosure Controls and Procedures

 

We carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based upon that evaluation, our principal executive officer and principal financial officer concluded that, as of the end of the quarter covered in this report, our disclosure controls and procedures were not effective to ensure that information required to be disclosed in reports filed under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the required time and is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure due to a material weakness in internal control over financial reporting.

 

Material Weaknesses

 

A material weakness is a deficiency, or a combination of deficiencies, within the meaning of Public Company Accounting Oversight Board Auditing Standard AS 2201, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. We had the following material weakness in internal control over financial reporting, characterized by the following:

 

 

●

We have not designed written policies and procedures at a sufficient level of precision to support the operating effectiveness of the controls to prevent and timely detect potential errors.

 

 

 

 

●

We did not maintain adequate documentation to evidence the operating effectiveness of certain control activities.

 

 

 

 

●

We did not maintain appropriate access to certain systems and did not maintain appropriate segregation of duties related to processes associated with those systems.

 

To address the material weaknesses, we performed additional analysis and other post-closing procedures in an effort to ensure our consolidated financial statements included in our periodic reports filed with the SEC are prepared in accordance with generally accepted accounting principles. Notwithstanding the material weakness, management believes that the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q fairly present in all material respects our financial condition, results of operations and cash flows for the periods presented in accordance with U.S. generally accepted accounting principles.

 

43


Table of Contents

 

Remediation Efforts

 

Management is committed to remediating the material weaknesses described above. During the nine months ended  September 30, 2026  the Company engaged an external CPA firm and an external consultant to augment its external reporting review process. The Company’s remediation efforts are ongoing and include, among other things: (i) formalizing written policies and procedures for key financial reporting processes at a level of precision sufficient to support the operating effectiveness of the related controls; (ii) enhancing documentation practices to evidence the design and operating effectiveness of control activities; and (iii) evaluating and implementing appropriate access controls and segregation of duties within key systems. While the Company believes these actions will remediate the identified material weaknesses, the material weaknesses will not be considered fully remediated until the applicable controls have operated effectively for a sufficient period of time and management has concluded, through testing, that the controls are operating effectively. We will continue to monitor and evaluate the effectiveness of our remediation efforts in subsequent periods.

 

Changes in Internal Control Over Financial Reporting

 

There were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II OTHER INFORMATION

 

Item 1. Legal Proceedings

 

From time to time, we are involved in lawsuits, claims, investigations, and proceedings that arise in the ordinary course of business. We are not presently a party to any material pending or threatened legal proceedings, nor do we have any knowledge of any such pending claims.

 

Item 1A. Risk Factors

 

In addition to the other information set forth in this Quarterly Report, you should carefully consider the factors discussed in Part I, “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025, which could materially affect our business, financial condition, liquidity, or future results. The risks described in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, liquidity or future results.

 

44


Table of Contents

 

Except as set forth below, there have been no material changes to the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025:

 

 

●

Nasdaq Minimum Bid Price Deficiency. Our common stock does not currently satisfy Nasdaq’s $1.00 minimum bid price requirement, and we have until February 9, 2027 to regain compliance. If we do not regain compliance, we may be eligible for an additional compliance period only if applicable conditions are met, may need to effect a reverse stock split, and could ultimately be delisted, which would adversely affect the liquidity and market price of our common stock. Although our shareholders authorized our Board of Directors at our 2026 Annual Meeting to effect one or more reverse stock splits at a ratio of not less than 1-for-2 and not greater than 1-for-250, a reverse stock split may not result in a sustained increase in the market price of our common stock. In addition, because we effected a 1-for-10 reverse stock split in March 2025, under Nasdaq Listing Rule 5810(c)(3)(A)(iv) we would not be eligible for any compliance period for a future bid price deficiency if, at that time, we had effected a reverse stock split during the prior one-year period, or reverse stock splits during the prior two-year period with a cumulative ratio of 250 shares or more to one.

 

 

 

 

●

Dilution and Option Plan Approval. Our option exchange program and new option grants covering 2,400,000 shares could dilute existing shareholders, and the related awards include grants to the holder of our Series A preferred stock. To the extent these awards exceed the shares available under the 2022 Plan, they may not be exercised unless shareholders approve an increase in the 2022 Plan share reserve or sufficient shares become available under the plan’s evergreen provision. If sufficient shares have not become available by the date of our 2027 annual meeting of shareholders, we will submit a proposal to increase the 2022 Plan share reserve at that meeting, and any portion of the awards that then exceeds the available shares will be forfeited if our shareholders do not approve it. If the awards are forfeited, our ability to retain and motivate personnel could be adversely affected.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

 

●

During the three months ended September 30, 2026, the Company issued an aggregate of 21,702 shares of common stock to consultants and service providers as compensation for services rendered.

 

 

 

The Company did not receive any cash proceeds from these issuances. The shares were issued in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended, as transactions by an issuer not involving a public offering. In reliance on representations made by each recipient, the Company determined that each recipient was an accredited investor, or had such knowledge and experience in financial and business matters that the recipient was capable of evaluating the merits and risks of the investment, acquired the shares for investment and not with a view to distribution, and had access to information about the Company. The shares are restricted securities and bear a restrictive legend. No underwriter or placement agent participated in these issuances, and no underwriting discounts or commissions were paid.

 

Purchases of Equity Securities by the Issuer and Affiliated Purchasers

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

45


Table of Contents

 

Item 5. Other Information

 

Securities Trading Plans

 

During the three months ended September 30, 2026, none of our Section 16 officers or directors (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any “non-Rule 10b5-1 trading arrangement” (as defined in Section 408(c) of Regulation S-K).

 

Subsequent Events

 

The following information is provided in lieu of a Current Report on Form 8-K under Item 5.02(e) of Form 8-K. The Company intends to file the related agreements as exhibits to its Annual Report on Form 10-K for the year ending December 31, 2026, and the descriptions below are qualified in their entirety by reference to those documents.

 

 

●

On November 9, 2026, the Board of Directors of the Company, upon the recommendation of the Compensation Committee, by unanimous written consent, approved an option exchange program under the 2022 Equity Incentive Plan, as amended (the “2022 Plan”), under which holders of outstanding options granted under the Company’s 2015 Equity Incentive Plan (which expired in 2025, although options granted under it remain outstanding in accordance with their terms), 2021 Equity Incentive Plan and 2022 Plan may surrender their options in exchange for new options under the 2022 Plan on a one-for-one basis. The new options will be non-qualified stock options with a ten-year term and an exercise price equal to the closing price of the common stock on The Nasdaq Capital Market on the grant date, and will vest one-third on the grant date, one-third on the first anniversary and one-third on the second anniversary of the grant date, subject to continued service, with time-based vesting replacing any performance-based vesting. The grant date will be November 13, 2026, which is the first trading day after two full trading days have elapsed following the filing of this Quarterly Report on Form 10-Q. Each exchange will be documented in an option exchange agreement, and the election period will remain open for at least 20 business days and at least 30 calendar days after the exchange documents are delivered. Only options that are outstanding and have not expired or otherwise terminated at the end of the election period are eligible. Options granted outside the Company’s equity incentive plans, including options issued by Terravis Energy Inc., are not eligible. To the extent the new options exceed the shares available under the 2022 Plan, they may not be exercised unless and until either the Company’s shareholders approve an amendment to the 2022 Plan to increase the number of shares of common stock reserved for issuance under the 2022 Plan or sufficient shares become available under the 2022 Plan, including through the automatic quarterly increases under its evergreen provision. If sufficient shares have not become available by the date of the Company’s 2027 annual meeting of shareholders, the Company will submit a proposal to increase the 2022 Plan share reserve at that meeting, and any new options that then exceed the available shares will be forfeited if the shareholders do not approve it. The Company will conduct the exchange program as an issuer tender offer.


The option exchange offer has not yet commenced. When the exchange offer commences, the Company will file a Tender Offer Statement on Schedule TO with the Securities and Exchange Commission (the “SEC”). Option holders should read the Schedule TO and its exhibits, including the offer to exchange, when they become available, because they will contain important information about the exchange offer. Option holders may obtain these documents free of charge at the SEC’s website at www.sec.gov or from the Company. This Quarterly Report on Form 10-Q is neither an offer to purchase nor a solicitation of an offer to sell any securities.

 

 

 

 

46


Table of Contents

 

 

 

 

●

On November 9, 2026, the Board of Directors of the Company, upon the recommendation of the Compensation Committee, by unanimous written consent, approved grants under the 2022 Plan of non-qualified stock options to purchase 2,200,000 shares to Steven Rossi, Chairman and Chief Executive Officer, and 50,000 shares to each of directors Lorenzo Rossi, Ned Siegel, Craig Loverock and William Caragol, with the same grant date, exercise price, vesting terms and ten-year term as the new options described above. Each grant will be satisfied first from the shares available under the 2022 Plan on the grant date, after reserving the maximum number of new options issuable in exchange for options granted under the 2015 and 2021 Equity Incentive Plans. To the extent a grant exceeds those available shares, the excess may not be exercised unless and until either the Company’s shareholders approve an increase in the 2022 Plan share reserve or sufficient shares become available under the 2022 Plan, including through the automatic quarterly increases under its evergreen provision. If sufficient shares have not become available by the date of the Company’s 2027 annual meeting of shareholders, the Company will submit a proposal to increase the 2022 Plan share reserve at that meeting, and any portion of the grant that then exceeds the available shares will be forfeited if the shareholders do not approve it. Each recipient abstained from the approval of his own grant.

 

 

 

 

●

On November 9, 2026, the Board of Directors of the Company, upon the recommendation of the Compensation Committee, by unanimous written consent, approved (i) Amendment No. 1 to the Consulting Agreement, dated as of July 23, 2024, among the Company, 2230164 Ontario Inc. and Steven Rossi, which provides for a transaction bonus equal to 10% of the consideration received by the Company upon the sale of a subsidiary, payable in cash or in kind, subject to a Section 280G cutback and a change-in-control non-competition agreement, and (ii) a transaction bonus and carve-out plan establishing a bonus pool of 4% of the consideration received by the Company in a qualified strategic transaction involving its Worksport or Terravis Energy businesses, with participants including Jennifer Kartychak, Chief Financial Officer (whose award equals 1.00% of the transaction consideration), other members of senior management, and independent directors William Caragol, Craig Loverock, and Ned Siegel. Each award under the plan is subject to a Section 280G cutback conditioned on the participant's execution of a change-in-control non-competition agreement.

 

 

 

The Company is evaluating the incremental compensation cost associated with the modification of the disclosed option exchange program under ASC 718.

47


Table of Contents

 

Item 6. Exhibits

 

Exhibit No.

 

Description

Previously filed and incorporated by reference herein:

 

 

 

 

4.1

 

Form of Inducement Warrant, dated August 27, 2026

Exhibit 4.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on August 27, 2026

10.1

 

Form of Inducement Letter, dated August 27, 2026

Exhibit 10.1 to the Company's Current Report on Form 8-K filed with the Securities and Exchange Commission on August 27, 2026

31.1*

 

Section 302 Certification of Chief Executive Officer

 

31.2*

 

Section 302 Certification of Chief Financial Officer

 

32.1**

 

Section 906 Certifications of Chief Executive Officer

 

32.2**

 

Section 906 Certifications of Chief Financial Officer

 

101.INS*

 

Inline XBRL Instance Document

 

101.SCH*

 

Inline XBRL Taxonomy Extension Schema Document

 

101.CAL*

 

Inline XBRL Taxonomy Extension Calculation Linkbase Document

 

101.LAB*

 

Inline XBRL Taxonomy Extension Label Linkbase Document

 

101.PRE*

 

Inline XBRL Taxonomy Extension Presentation Linkbase Document

 

101.DEF*

 

Inline XBRL Taxonomy Extension Definition Linkbase Document

 

104*

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

*

Filed herewith.

 

 

**

Exhibits 32.1 and 32.2 are being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise specifically stated in such filing.

 

48


Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

 

WORKSPORT LTD.

 

 

 

Dated: November 10, 2026

By:

/s/ Steven Rossi

 

 

Steven Rossi

 

 

Chief Executive Officer

 

 

(Principal Executive Officer)

 

 

 

Dated: November 10, 2026

By:

/s/ Jennifer Kartychak

 

 

Jennifer Kartychak

 

 

Chief Financial Officer

 

 

(Principal Financial Officer)

 

 

(Principal Accounting Officer)

 

49

Keep reading